There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 73870-24-3 | MDL No. : | MFCD01863545 |
Formula : | C6H7Br2N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VAJUUDUWDNCECT-UHFFFAOYSA-N |
M.W : | 252.93 | Pubchem ID : | 12752219 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.11 |
TPSA : | 12.89 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.09 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.47 |
Log Po/w (WLOGP) : | 2.78 |
Log Po/w (MLOGP) : | 1.8 |
Log Po/w (SILICOS-IT) : | 2.4 |
Consensus Log Po/w : | 1.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.39 |
Solubility : | 0.103 mg/ml ; 0.000406 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.39 |
Solubility : | 1.04 mg/ml ; 0.00412 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.28 |
Solubility : | 0.134 mg/ml ; 0.00053 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.55 |
Signal Word: | Danger | Class: | 8 |
Precautionary Statements: | P501-P260-P264-P280-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P405 | UN#: | 3261 |
Hazard Statements: | H314 | Packing Group: | Ⅱ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58.1% | With phosphorus pentabromide In chloroform | 67a 4-bromomethyl pyridine hydrobromide To a solution of 4-pyridylcarbinol (3 g, 27.5 mmol) in 30 mL of CHCl3 was added phosphorus pentabromide (5.93 g, 13.7 mmol). The solution was refluxed for 1 hour. The solvent was removed in vacuo and recrystallized in ethanol to afford the title compound as a white solid (4.05 g, 58.1percent). ES (+) MS m/e=173 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With sodium hydroxide; tetrabutylammomium bromide; In toluene; for 10h;Heating / reflux; | To a solution of 2-hydroxyphenyl 7-chloro-3-(pyrrolidin-l-yl)-quinoline-8-carboxylate (3.3 g) in toluene (50 ml) were added tetrabutylammonium bromide (0.8 g), sodium hydroxide (1.7 g) and 4- (bromomethyl)pyridine hydrobromide(2.2 g), and reflux was conducted for 10 hrs. The reaction solution was cooled to room temperature and subjected to extraction with ethyl acetate. The extract was dried over <n="21"/>anhydrous magensium sulfate and concentrated in a vacuum, followed by purification through to afford the object compound (3.2 g, 78%).1H NMR(SOO MHz, CDCl3) delta 8.82 - 6.84(m, 12H), 5.20(s, 2H), 2.88(m, 4H), 1.59(m, 4H);MS m/z 459(M+) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | With potassium carbonate; In acetonitrile; at 0 - 20℃; for 2h; | To a stirred solution of (2S)-3-(4-{2-[(lalpha,5alpha56alpha)-(3-azabicyclo[3.1.0]hex-6-yl)-rert- butoxy-carbonylamino]ethoxy}phenyl)-2-ethoxypropionic acid ethyl ester (Intermediate 13; 0.505 g, 1.09 mmol) in dry acetonitrile (18 ml) was added anhydrous potassium carbonate (0.91 g, 6.56 mmol) and 4-bromomethylpyridine hydrobromide (0.29 g, 1.1 mmol) at 0 0C. The reaction mixture was allowed to come to room temperature and stirred for 2 h. Solvent was removed under reduced pressure and the residue was dissolved in ethyl acetate (35 ml) washed with water (1x5 ml). The organic layer was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to yield the crude product, which was purified by <n="213"/>column chromatography over silica gel (100-200 mesh) using 0.8-M.2 methanol- dichloromethane as an eluent to yield the title compound (0.470 g, 77%). MS: m/z 554 (M+l), 576 (M+23)1HNMR (CDCl3, 400 MHz): delta 1.13 (t, J = 6.8 Hz, 3H), 1.21-1.26 (m, 12H), 1.85-1.90 (m, 3H),' 2.55-2.60 (m, 2H), 2.92 (d, J= 5.6 Hz, 2H), 3.30-3.37 (m, 2H), 3.52-3.65 (m, 4H), 3.70- 3.77 (m, 2H), 3.93 (t, J= 6.4 Hz, IH)5 4.02 (t, J= 4.8 Hz, 2H), 4.13 (q, J= 6.8 Hz, 2H), 6.76 (d, J= 8.4 Hz, 2H), 7.04 (d, J= 8.0 Hz, 2H), 7.35-7.40 (m, 2H), 8.50-8.59 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
28% | With tetra-(n-butyl)ammonium iodide; potassium carbonate; In acetone; at 20℃; | Ethyl 4- (4-cyanophenyl)-6-methyl-2-thioxo-1- [3- (trifluoromethyl) phenyl] -1,2, 3,4- tetrahydro-5-pyrimidinecarboxylate (Example 3; 100 mg, 0.22 mmol), [4- (BROMO-] methyl) pyridine hydrobromide (62.5 mg, 0.25 mmol), N, [N, N-TRIBUTYL-L-BUTAN-] aminium iodide (7 mg, 0.03 mmol) and potassium carbonate (65.2 mg, 0.47 mmol) are dissolved in 3 ml acetone and stirred at room temperature overnight. The solvent is removed in vacuo and the product is purified via preparative HPLC (RP18- column; eluent: acetonitrile-water, gradient 10: 90 to 90: 10). Yield: [34 MG] (28% of th.) LC-MS (method 3): Rt = 3.92 min. MS (ESIpos): [M/Z =] 537 [(M+H) +] [IH-NMR] (200 MHz, [DMSO-D6)] : [8] = 8.34 (m, 2H) ; 7.89 (m, 2H); 7.82 (d, 2H); 7.72 (m, 2H); 7.57 (d, 2H); 7.53 (m, 1H); 7.13 (dd, 1H); 5.78 (s, [LH)] ; 3.94-4. 14 (m, 4H); 2.00 (s, 3H); 1.10 (t, 3H) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With potassium carbonate; In DMF (N,N-dimethyl-formamide); at 20℃; | To a solution of ethyl N-[4-(piperidin-4-yloxy)-3-chlorophenyl]-N-[3-(3-cyanophenyl)-2-(E)-propenyl]sulfamoylacetate (1.10 g) obtained in reference example 71 in N,N-dimethylformamide (30 ml) were added successively <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (0.59 g) and potassium carbonate (0.59 g) with stirring at room temperature, and the resulting mixture was stirred at room temperature overnight. After stirring, the reaction mixture was diluted with ethyl acetate, and the organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate and evaporated in vacuo. The residue obtained was purified by chromatography on a silica gel column using a mixed solvent of ethyl acetate and methanol (10:1) as the eluent to afford the title compound (0.97 g, yield: 75 %) as a pale yellow amorphous solid. 1H NMR (500MHz, CDCl3) delta ppm : 1.36 (3H, t, J=7.0), 1.86-1.95 (2H, m), 1.95-2.04 (2H, m), 2.38 (2H, m), 2.70 (2H, m), 3.53 (2H, s), 3.98 (2H, s), 4.31 (2H, q, J=7.0), 4.43 (1H, m), 4.46 (2H, d, J=6.5), 6.22 (1H, dt, J=16.0, 6.5), 6.41 (1H, d, J=16.0), 6.92 (1H, d, J=9.0), 7.28 (2H, d, J=6.0), 7.31 (1H, dd, J=9.0, 2.5), 7.40 (1H, t, J=8.0), 7.49-7.54 (2H, m), 7.53 (1H, d, J=2.5), 7.55 (1H, s), 8.54 (2H, d, J=6.0). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | Reference Example 1 2-(4-Pyridylmethylthio)pyridine-3-carboxylic acid (Reference compound No.1-1) 2-Mercaptonicotinic acid (7.8 g, 50 mmol) and <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (12.6 g, 50 mmol) were suspended in N,N-dimethylformamide (100 mL) under ice-cooling. Triethylamine (21 ml, 150 mmol) was added dropwise to the suspension, and the whole was stirred at room temperature for 6 hours. Water (300 mL) was added to the reaction mixture, then the aqueous layer was washed with ethyl acetate (100 mL). 2 N hydrochloric acid was added to the aqueous layer to adjust to pH 7, and the precipitated solid was filtered off. The solid was washed with water and diethyl ether, and dried at 50C under reduced pressure to give 7.5 g of the title reference compound as a gray solid. (Yield 61%) 1H-NMR(400MHz,DMSO-d6) delta 4.38(s,2H),7.27(dd,J =8.1,4.8 Hz,1H),7.42(dd,J = 4.4,1.5 Hz,2H),8.22(dd,J = 8.1,1.8 Hz,1H),8.46(dd,J = 4.4,1.5 Hz,2H),8.63(dd,J = 4.8,1.8 Hz,1H),13.70(br s,1H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | 6-fluoroisatoic anhydride (79, 0.3 g, 1.65 mmol) was dissolved in anhydrous DMA (8 mL). The solution was stirred under an N2 atmosphere and NaH (0.073 g, 1.82 mmol, 60% dispersion in mineral oil) was added. The mixture was stirred for 10 min and additional sodium hydride (0.066 g, 1.65 mmol) was added followed by a solution of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (0.46 g, 1.82 mmol) and DMA (10 mL). The reaction was heated to 70 C. for 3 h, cooled to room temperature and finally in an ice bath. The reaction mixture was poured into a cold saturated NH4Cl solution (150 mL) and thrice extracted with EtOAc (75 mL). The combined organic layers were washed with water (40 mL), brine. The solution was dried (Na2SO4), filtered and evaporated to afford a solid which was dried in a vacuum then triturated with Et2O/hexane (1:2) to afford 300 mg (66%) of 81: ms [M+H]+=273. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4-Nitro-1-pyridin-4-ylmethy1-lH-indole: To a cooled solution of 1.0 g (6.2 mmol, leq.) of 4-nitroindole in 25 mL of THF is added 0.44 g (19 mmol, 3 eq.) of NaH (95% dry). The resulting reaction mixture is stirred at 0 C for 30 min and treated with 2.3 g (9.3 mmol, 1.5 eq.) of 4-bromomethylpyridine hydrobromide and the reaction mixture is stirred for 16 hrs while warming up to rt. Water is added and the aqueous layer was extracted with EtOAc (3 x 75 mL), the organic layers combined and dried over anhydrous MgSO4. The resulting solid is then purified by column chromatography (5% MeOH : 95% EtOAc) affording 4-nitro-1-pyridin-4-ylmethyl-lH-indole as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4-Nitro-1-pyridin-4-ylmethyl-lH-indazoIe: To a cooled solution of 4- EPO <DP n="47"/>nitroindazole (1.0 g, 6.10 mmol) in THF (25 mL) is added NaH (0.44 g, 95%, 18.0 mmol). The resulting reaction mixture is stirred at 0 C for 30 min then treated with 4- bromomethylpyridine hydrobromide (2.3 g, 9.2 mmol, 1.5 eq.) and the reaction mixture is stirred for 16 hrs while warming up to rt. Water (25 mL) is added and the aqueous layer is extracted with EtOAc (3 x 75 mL), and the organic layers are combined and dried over anhydrous MgSO4. The resulting crude is then purified by column chromatography (5% MeOH : 95% EtOAc) to afford 4-nitro-1-pyridin-4-ylmethy1-lH-indazole as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 89 3-Cyclohexyl-2-[2-(2,4-dimethyl-thiazol-5-y1)-quinolin-6-y1]-l-pyridin-4-y1methyl- 1H-indole-6-carboxylic acid (289)[0321] To a solution of the indole compound 137 (94 mg, 0.19 mmol) in DMF (2 mL) was added NaH ( 27 mg, 5 eq). After 5 minutes stirring at room temperature 4- bromomethyl pyridine hydrobromide was added and the mixture stirred for 4 hours. The reaction was then quenched with water (1 mL) which precipitated the product. It was then spun down to a pellet and redissolved in 5 mL of methanol : water (5% LiOH) and heated to 50 C for 8 hrs. The product was then purified by RP-HPLC.Yield 35.2 mg, 30%. MS: 573.2 (M+H+); H1-NMR (DMSO-d6): delta(rhorhom) 8.61 (d, 2H, J=5.1), 8.44 (d, 1H, J=8.1), 8.01-7.62 (m,7H), 7.2 (d, 1H, J= 5.1), 5.6 (s, 2H), 2.69 (s, 3H), 2.65 (s, 3H), 2.62 (m, 1H) 1.95-1.10 (m, 10H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
NaH (60%) (120 mg, 3 mmol) was added into a solution of dichloro-2-(2,2,2-trifluoro-ethyl)-1H-benzoimidazole (269 mg, 1 mmol) in DMF (5 ml) at 0C. The resulting mixture was stirred at 0C for half hour. <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> (379.5 mg, 1.5 mmol) was then added to the reaction mixture at 0C. The reaction temperature was raised to 25C and then the reaction mixture was stirred for 18 hours. NH4Cl (aq.) was added and extracted with EtOAc. The organic layer was washed with brine, then dried over anhydrous MgSO4. The solvent was distilled out under reduced pressure. Column chromatography (silica gel, EtOAc / hexanes (30% to 100%) yielded the title compound as a white solid. MS m/z (M+H) 360. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
22% | With triethylamine; In dichloromethane; at 20℃; for 6h; | The thiol (32mg, 0.127mmol), 4-bromomethylpyridine hydrobromide (40mg, 0.106mmol) and triethylamine (32ul, 0.2296 mmol) were added to anhydrous dichloromethane (1.5ml) and stirred for 6h at room temperature. The mixture was quenched with water, the organics extracted with dichloromethane (3 x 10ml) and evaporated to a residue. Preparative thin layer chromatography (SiO2, 1% MeOH in dichloromethane) yielded the 4-pyridinyl phenoxazine (13mg, 22%) as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.1. Ethyl 5-fluoro-1-[(pyrid-4-yl)methyl]-1H-indole-2-carboxylate A solution of 1 g (4.73 mmol) of <strong>[348-36-7]ethyl 5-fluoro-1H-indole-2-carboxylate</strong> is added dropwise to a suspension of 0.38 g (9.45 mmol) of 60percent sodium hydride in 10 ml of dimethylformamide, stirred at 0° C. under argon. The mixture is stirred for 30 minutes at 0° C. and then for 30 min at 20° C. The reaction mixture is cooled and 1.24 g (4.2 mmol) of 4-bromomethylpyridine hydrobromide are added portionwise. The mixture is stirred for 30 minutes at 0° C. and then for 30 minutes at 20° C. The reaction mixture is cooled again to 0° C. and a further 0.38 g (9.45 mmol) of 60percent sodium hydride in 10 ml of dimethylformamide is added. After 30 minutes at 0° C., 1.24 g (4.2 mmol) of 4-bromomethylpyridine hydrobromide are added portionwise. The reaction mixture is then stirred for 20 hours at 20° C. After this time, the mixture is poured into a solution of 100 ml of ice-water and 100 ml of ethyl ether. The organic phase is separated out and the aqueous phase is re-extracted with 100 ml of ethyl ether. The organic phases are combined, washed with 50 ml of water and then dried over sodium sulfate, filtered and then concentrated under reduced pressure. The residue is purified by preparative chromatography (eluent: dichloromethane/acetone). 0.65 g of expected product is obtained in the form of an oil, which is used without further purification in the subsequent synthesis. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | With sodium hydride; In N,N-dimethyl-formamide; at 90℃; | Example 21.1: 2-(4-{2-[4-(Pyridin-4-ylmethoxy)-phenyl]-acetyI}-piperazin-1-yl)-nicotinonitrile. A mixture of 2-{4-[2-(4-hydroxy-phenyl)-acetyl]-piperazin-l-yl}-nicotinonitrilc (Example 1.4) (500 mg, 1.55 mmol), sodium hydride (75 mg, 3,12 mmol), 4-bromomethyl- pyridine hydrobromide (393 mg, 1,55 mmol) and N,N-dimethylformamide (20 mL) was stirred at 90 C. The reaction mixture was cooled to room temperature, quenched with water and diluted with ethyl acetate. The organic layer was separated, washed with water, washed with brine, dried over sodium sulfate, filtered and concentrated. The residue was purified on silica gel to give 2-(4- {2- [4-(pyridin-4-ylmethoxy)-phenyl] -acetyl } -piperazin-1-yl)- nicotinonilrile (1 15 mg, 18 %). 1H NMR (300 MHz, CDCl3): delta(ppm) 8.35 (bs, 2H), 8.08 (dd, <n="43"/>IH), 7.52 (dd, IH), 7.10 (m, 2H), 6.95 (d, 2H), 6.67 (d, 2H), 6.55 (m, IH), 4.82 (s, 2H), 3.53 (m, 2H), 3.48 (s, 2H), 3.38 (m, 4H), 3.27 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With triethylamine; In N,N-dimethyl-formamide; at 20℃; | Step 2; A solution of the dihydrochloride salt of step 1, above (65 mg, 0.12 mmol) was dissolved in DMF (2.0 mL) and <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (2×35 mg, 2×0.14 mmol) and triethylamine (2×80 muL, 2×58 mg, 2×570 mumol) were added. The resulting reaction mixture was allowed to stir at room temperature overnight, poured into saturated sodium bicarbonate solution (20 mL) to give an off-white solid which was triturated with ethyl ether to provide N-(1-(pyridin-4-ylmethyl)piperidin-4-yl)-2-(4-(trifluoromethyl)benzyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-carboxamide (Compound 50, 60%). 1H NMR (DMSO-d6, 300 MHZ) 11.02 (s, 1H), 8.49 (d, J=4.7 Hz, 2H), 7.99 (d, J=8.0 Hz, 1H), 7.84 (s, 1H), 7.71 (d, J=8.0 Hz, 2H), 7.62 (d, J=8.3 Hz, 2H), 7.55 (d, J=8.3 Hz, 1H), 7.31 (d, J=4.7 Hz, 2H), 7.25 (d, J=8.3 Hz, 1H), 3.86 (s, 2H), 3.82-3.70 (m, 1H), 3.63 (s, 2H), 3.50 (s, 2H), 2.90-2.74 (m, 6H), 2.06 (t, J=11.1 Hz, 2H), 1.77 (d, J=10.2 Hz, 2H), 1.60 (q, J=10.9 Hz, 2H) ppm; MS (ES) 548 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49% | With caesium carbonate; In N,N-dimethyl-formamide; at 60℃; for 3h; | a) Methyl 2-{2-[4-(pyridin-4-ylnnethoxy)phenyl]ethyl}-5-phenylpentanoate 4-(Bromonnethyl)py?dine hydrobromide (500 mg, 1.976 mmol) was added to a suspension of methyl 2-[2-(4-hydroxyphenyl)ethyl]-5-phenylpentanoate (400 mg, 1.28 mmol) and Cs2CO3 (1.30 g, 3.98 mmol) in DMF (20 ml_). The reaction mixture was warmed up to 60 0C and stirred for 3 h. It was allowed to reach r.t. and poured into H2O (150 ml_), taken up to pH = 3 with HCI and extracted with Et2O (100 ml_). The organic layer was dried over Na2SO4 (anhydrous), filtered and concentrated. The crude residue was purified by flash chromatography on SiO2 (10?80% EtOAc/hexanes), to give 245 mg of methyl 2-{2-[4-(pyridin-4-ylmethoxy)phenyl]ethyl}-5-phenylpentanoate(colourless oil, yield: 49%).1H NMR (CDCI3, 250 MHz) delta ppm: 8.60 (m, 2H), 7.34 (m, 2H), 7.26 (m, 2H), 7.21 -7.03 (m, 5H), 6.85 (m, 2H), 5.07 (s, 2H), 3.67 (s, 3H), 2.61 -2.33 (m, 5H), 1.90 (m, 1 H), 1.75-1.46 (m, 5H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | To 50 mL of DMF (50 mL) at RT was gradually added with stirring NaOMe (4.13 g, 76 mmol) and the resulting reaction mixture was cooled to 5-10. Diethyl malonate (11.6 mL, 76 mmol) was added to the reaction mixture and stirred at RT for 1h. 4-(Bromomethyl)pyridine hydrobromide 5 (12 g, 47 mmol) dissolved in DMF (22 mL) was added to the reaction mixture over a period of 10 min at 5 -10 . The resulting reaction mixture was stirred for 6h at RT. After completion of the reaction by TLC, the reaction mixture was quenched with ice cold water (500 ml) and extracted with DCM (2 x 250 mL). The combined organic layers were dried over Na2SO4. Filtered the organic layer and concentrated under reduced pressure to give crude product as pale red color oil. The obtained crude compound was purified by column chromatography (SiO2, 60-120 mesh, 40% EtOAc/hexane) to get diethyl 2-(pyridin-4-ylmethyl)malonate 6 (9.4 g, 79%) as pale red color oil. 1H NMR (400 MHz, CDCl3): 1.19 (t, 6H, J = 7.2 Hz), 3.22 (d, 2H, J = 7.6 Hz), 3.63 (t, 1H, J = 7.6 Hz), 4.14 (m, 4H) 7.23 (d, 2H, J = 6.4 Hz) 8.51 (d, 2H, J = 3.2 Hz); 13C NMR (100 MHz, CDCl3): 13.91, 14.05, 33.80, 52.46, 52.65, 61.78, 124.01, 124.18, 146.93, 149.86, 149.94, 168.32; Mass: m/z = 252.1 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In N,N-dimethyl-formamide; mineral oil; | Step 3 To a suspension of NaH (170 mg of a 60% dispersion in mineral oil, 4.25 mmol) in anhydrous DMF (20 ml) is added 2,2,2-trifluoro-N-{4-[(2,2,2-trifluoro-acetylamino)-methyl]-piperidin-4-yl}-acetamide hydrochloride) (500 mg, 1.4 mmol) followed by 4-bromomethylpyridine hydrobromide (350 mg, 1.4 mmol). The reaction mixture is stirred at room temperature for 3 hours. The reaction mixture is quenched with sat. NH4Cl solution and is concentrated in vacuo. The residue is purified by column chromatography (basic alumina, MeOH/DCM) to obtain 2,2,2-Trifluoro-N-[1-pyridin-4-ylmethyl-4-(2,2,2-trifluoro-acetylamino)-piperidin-4-ylmethyl]-acetamide as off-white solid; [M+H]+ 413. | |
With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 20℃; for 3h; | To a suspension of NaH (170 mg of a 60% dispersion in mineral oil, 4.25 mmol) in anhydrous DMF (20 ml) is added 2,2,2-trifluoro-N-{4-[(2,2,2-trifluoro-acetylamino)-methyl]-piperidin-4-yl}-acetamide hydrochloride) (500 mg, 1.4 mmol) followed by 4-bromomethylpyridine hydrobromide (350 mg, 1.4 mmol). The reaction mixture is stirred at room temperature for 3 hours. The reaction mixture is quenched with sat. NH4Cl solution and is concentrated in vacuo. The residue is purified by column chromatography (basic alumina, MeOH/DCM) to obtain 2,2,2-Trifluoro-N-[1-pyridin4-ylmethyl-4-(2,2,2-trifluoro-acetylamino)-piperidin-4-ylmethyl]-acetamide as off-white solid; [M+H]+ 413. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; | Step 1 3-[4-(Pyridin-4-ylmethoxy)-phenyl]-propionic acid To a solution of Methyl 3-(4-hydroxyphenyl)propanoate (0.5 g, 2.77 mmol) in dry DMF (10 ml) is added potassium carbonate (0.76 g, 5.55 mmol) followed by <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (0.7 g, 2.77 mmol). The reaction mixture is stirred at room temperature overnight then poured into water (80 ml) and extracted with EtOAc (40 ml). The organic phase is washed with brine, dried (MgSO4) and the solvent removed in vacuo to yield a dark brown oil. Chromatography (SiO2, EtOAc) yields 3-[4-(Pyridin-4-ylmethoxy)-phenyl]-propionic acid methyl ester as a colourless oil; [M+H]+ 272.0 | |
With potassium carbonate; In N,N-dimethyl-formamide; | Step 1 3-[4-(Pyridin-4-ylmethoxy)-phenyl]-propionic acid To a solution of Methyl 3-(4-hydroxyphenyl)propanoate (0.5 g, 2.77 mmol) in dry DMF (10 ml) is added potassium carbonate (0.76 g, 5.55 mmol) followed by <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (0.7 g, 2.77 mmol). The reaction mixture is stirred at room temperature overnight then poured into water (80 ml) and extracted with EtOAc (40 ml). The organic phase is washed with brine, dried (MgSO4) and the solvent removed in vacuo to yield a dark brown oil. Chromatography (SiO2, EtOAc) yields 3-[4-(Pyridin-4-ylmethoxy)-phenyl]-propionic acid methyl ester as a colorless oil; [M+H]+ 272.0. | |
With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; | To a solution of Methyl 3-(4-hydroxyphenyl)propanoate (0.5 g, 2.77 mmol) in dry DMF (10 ml) is added potassium carbonate (0.76 g, 5.55 mmol) followed by <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (0.7 g, 2.77 mmol). The reaction mixture is stirred at room temperature overnight then poured into water (80 ml) and extracted with EtOAc (40 ml). The organic phase is washed with brine, dried (MgSO4) and the solvent removed in vacuo to yield a dark brown oil. Chromatography (SiO2, EtOAc) yields 3-[4-(Pyridin-4-ylmethoxy)-phenyl]-propionic acid methyl ester as a colorless oil; [M+H]+ 272.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | A mixture of methyl 5-bromo-3-[ (trifluoroacetyl) amino] thiophene-2-carboxylate (500 mg, 1.51 mmol) , 4- (bromomethyl) pyridine hydrobromide (457 mg, 1.81 mmol), cesium carbonate (1.72 g, 5.29 mmol) and DMA (15 mL) was stirred at 800C for 2 h. Then, water was added to quench the reaction. The organic materials were extracted with EtOAc. The combined extracts were washed with water and brine, dried over Na2SO4 and filtered. After removal of the solvent at reduced pressure, the residue was dissolved in MeOH (5 mL) . To the solution were added potassium carbonate (500 mg) and water (2.5 mL) . The mixture was stirred at room temperature for 2 h. After removal of the solvent at reduced pressure, the organic materials were extracted with EtOAc. The combined extracts were washed with brine, dried over Na2SO4 and filtered. After removal of the solvent at reduced pressure, the residue was purified by column chromatography (Purif, silica gel, hexane to 50:50 hexane/EtOAc) to give the title compound (238 mg, 48%) as a yellow solid: 1H NMR (300 MHz, CDCl3) delta 3.82 (3H, s) , 4.47 (2H, d, J = 6.2 Hz), 6.46 (IH, s), 7.23 (2H, d, J = 5.9 Hz), 7.34 (IH, br s) , 8.53-8.63 (2H, m) . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
26% | With triethylamine; In ethanol; at 20℃; | 6-methyl-2-sulfanylpyrimidin-4-ol (300 mg, 2.1 mmol) was dissolved in absolute ethanol (10 mL), then triethylamine (650 muL, 4.6 mmol) and 4-(bromomethyl)pyridin- 1-ium bromide (587 mg, 2.3 mmol) were added. The mixture was stirred overnight at room temperature, and the solvent was evaporated. The residue was dissolved in DCM and purified on silica gel using 10% DCM/MeOH to afford, after washing with water, 6-methyl-2-[(pyridin-4-ylmethyl)sulfanyl]pyrimidin-4-ol as white solid (128 mg, 26% yield); 1H NMR (400 MHz, MeOJ4): 62.24 (s, 3H), 4.47 (s, 2H), 6.00 (s, IH), 7.52 (dd, / = 4.5 Hz, J = 1.6 Hz, 2H), 8.45 (dd, J = 4.5 Hz, J = 1.6 Hz, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With caesium carbonate; In water; N,N-dimethyl-formamide; at 20℃; for 24h; | General procedure: The 7-alkoxy-1-methyl-beta-carbolines (3a-o) were synthesized according to a previously reported procedure.13 The appropriate alkyl halide (by portion) or 1-tosyl-4,4,4-trifluorobutane (for compound 3e) and cesium carbonate were added to harmol (2) dissolved in anhydrous dimethylformamide (DMF). Then, the reaction mixture was stirred at room temperature or heated for several hours. At the end of the reaction, the mixture was cooled and diluted with dichloromethane, washed once with water and three times with brine. The organic layer was dried over MgSO4 and concentrated. The crude product was purified by liquid chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | Step 3: tert- Butyl 3-(pyridin-4-ylmethoxy)azetidine-l-carboxylateA solution of A/-Boc-azetidin-3-ol (500 mg, 2.89 mmol) in THF (10 ml_) was cooled to 0 C. t-BuOK (1M in THF, 11.6 ml_) was added dropwise and the reaction mixture was stirred at room temperature for 0.25 h then cooled to 0 C. A solution of 4- bromomethylpyridine hydrobromide (2.19 g, 8.67 mmol) in dichloromethane (5 ml_) stirred with DIPEA (4 ml_, 24 mmol) for 0.5h was then added. The reaction mixture was stirred at room temperature for 24 h. The reaction mixture was diluted with H20 and extracted twice with EtOAc. The organics were separated from the aqueous layer and combined, dried over Na2S04 and concentrated to dryness. The crude mixture was purified by column chromatography (eluent: Pentane/EtOAc, 1/1 to 7/3) to give the title product (313 mg, 41%) as a yellow oil.LCMS (ESI+) m/z 265 (M)+ : 28%.*H NMR (DMSO-c/e, 300 MHz) : delta (ppm) : 8.54 (d, J = 5.9 Hz, 2H), 7.34 (d, J = 5.9 Hz, 2H), 4.49 (s, 2H), 4.39-4.25 (m, 1H), 4.06-3.90 (m, 2H), 3.80-3.65 (m, 2H), 1.37 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With sodium hydride; In N,N-dimethyl-formamide; at 20℃; for 1h;Inert atmosphere; | To a solution of tert-butyl (1-(4-(2-oxo-7-phenyl-2,3-dihydro-1 H-pyrido[2,3-b][1 ,4]oxazin- 6-yl)phenyl)cyclobutyl)carbamate (35 mg, 0.07 mmol) in dry DMF (1 ml) was added sodium hydride (7 mg, 0.18 mmol) and 4-(bromomethyl)pyridine.HBr (23 mg, 0.09 mmol) under nitrogen. The resulting mixture was stirred for 1 hour at room temperature. A saturated solution of NaHC03 was added and the mixture was extracted with dichloromethane (3 x 10ml) using a phase separator (Isolute SPE). The combined organic phases were concentrated to dryness under reduced pressure. The resulting residue was purified by Biotage silica gel chromatography (gradient 0 to 80% EtOAc in cyclohexane) to give the title compound (21 mg, 50%). 1H NMR (500 MHz,CDCI3): 8.54 (2H,s), 7.19 -7.12 (9H,m), 6.97 (1 H,s), 6.93-6.91 (2H,m), 5.1 1 (2H, s), 4.98 (1 H, br s), 4.95 (2H, s), 2.52-2.20 (4H, m), 2.00-1.95 (1 H, m), 1.75 -1.70 (1 H, m), 1.44-1.15 (9H, br). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | With potassium carbonate; In acetonitrile; for 3h;Reflux; | To a round-bottom flask was charged with compound 12a (210 mg, 0.33 mmol), <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> salt (85 mg, 0.34 mmol), K2C03 (110 mg) and ACN (15 mL). The reaction mixture was stirred at refluxing temperature for 3 hr. When TLC indicated complete consumption of starting material, the reaction mixture was poured into a separating funnel containing water. The mixture was continuously extracted with CH2CI2. The combined organic layers were dried over MgS04, filtered and evaporated to give a crude reaction mixture, which was subjected to purification by flash column chromatography on silica gel with 10-20 % acetone in CH2CI2 as eluent to furnish the titled compound 21 as pale brown oil (130 mg, 54%): 1H NMR (CDCI3) delta 2.81 (t, J = 5.6 Hz, 4H), 3.63 (t, J = 6.0 Hz, 4H), 3.78 (t, J = 4.8 Hz, 4H), 3.84 (s, 2H), 4.14 (t, J = 4.8 Hz, 4H), 6.70 (s, 2H), 6.99 (d, J = 8.8 Hz, 4H), 7.30 (d, J = 5.2 Hz, 2H), 7.37 (dd, J = 8.0, 8.4 Hz, 2H), 7.51 (d, J = 8.4 Hz, 2H), 7.62 (dd, J = 8.0, 8.4 Hz, 2H), 7.83 (d, J = 8.8 Hz, 4H), 8.17 (d, J = 8.0 Hz, 2H), 8.49 (d, J = 5.2 Hz, 2H); 3C NMR (CDCI3) delta 54.2, 58.7, 67.6, 69.3, 70.0, 106.2, 115.0, 117.9, 123.7, 123.9, 124.2, 125.1 , 125.6, 127.9, 133.6, 149.6, 156.1 , 161.5, 163.2, 178.3; LRMS (ESI) m/z 725 (M+ + H, 25); HRMS (ESI) Calcd for C44H41N2Oa(M+ + H) 725.2863, found 725.2859 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | General procedure: NaH (60% in oil, 3 mol equiv.) was added in one portion to the alcohol 7 dissolved in dry THF (?5 mL/mmol) and the reaction mixture was stirred for 10 min under an Ar atmosphere. The substituted benzyl bromide (1-1.2 mol equiv.) was then added and the reaction mixture was stirred at rt for a period of 48-72 h. H2O (10-20 mL) was then added and the THF removed under reduced pressure. The remaining aqueous liquid was extracted with EtOAc or CH2Cl2 (3 × 20 mL), which was combined, washed with brine, dried over MgSO4 and removed in vacuo. The alkylated product was then obtained after column chromatography with flash silica. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37% | Example 55 N-Benzooxazol-2-yl-2-(4-methanesulfonyl-phenyl)-3-pyridin-4-yl-propionamide To a slurry of sodium hydride (29 mg of 60% in oil dispersion, 0.73 mmol) in DMF (1 mL) under nitrogen at 0 C. was added a solution of N-benzooxazol-2-yl-2-(4-methanesulfonylphenyl)acetamide (prepared as in example 5, 100 mg, 0.3 mmol) in DMF (2 mL). The reaction mixture was stirred at room temperature for 2 h. A suspension of 4-bromomethylpyridine hydrobromide (77 mg, 0.3 mmol) was suspended in DMF (1.5 mL) and to that was added sodium hydride (12 mg of 60% in oil dispersion, 0.3 mmol). The resulting 4-bromomethylpyridine solution was added to the above solution. The combined reaction mixture was stirred at room temperature for 2 h. The reaction mixture was quenched with saturated aqueous NH4Cl, diluted with H2O and extracted 1 time with ether and 2 times with CH2Cl2. The combined organic extracts were washed with saturated aqueous NaCl, dried over Na2SO4 and concentrated in vacuo. Purification by chromatography (silica, 1-3% methanol in CH2Cl2 gradient) afforded N-benzooxazol-2-yl-2-(4-methanesulfonyl-phenyl)-3-pyridin-4-yl-propionamide: 1H NMR (300 MHz, CHLOROFORM-d) delta ppm 2.94-3.19 (s, m, 5H) 3.61 (dd, J=13.94, 8.67 Hz, 1H) 7.13 (d, J=5.65 Hz, 2H) 7.19-7.33 (m, 3H) 7.34-7.51 (m, 2H) 7.57 (d, J=8.29 Hz, 2H) 7.84 (d, J=8.29 Hz, 2H) 8.40 (d, J=4.90 Hz, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With N,N,N?,N?-tetramethyl-N?-tert-butylguanidine; In acetonitrile; | Step A: Preparation of 3 -iodo-4-nitro- 1 -(pyridin-3 -ylmethyl)- 1 H-indazole : To a flask was added 3 -iodo-4-nitro-l H-indazole (0.300 g, 1.04 mmol) and 4- (bromomethyl)pyridine hydrobromide (0.315 g, 1.25 mmol) which were slurried in CH3CN (5.0 mL). 2-tert-Butyl-l,l,3,3-tetramethylguanidine (0.460 mL, 2.28 mmol) was added and the mixture was stirred overnight. The mixture was diluted with water (20 mL) and stirred for 15 minutes and filtered. The collected solids were washed with water followed by Et20 and hexanes, and dried under vacuum to provide the title compound as a brown powder (0.304 g, 71%), which was used directly in the subsequent step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 80℃; for 48h; | The following compounds or the precursors to them were prepared according to general route 3: 2-(5-methoxy-2-methyl-l-^yridin-4-ylmethyl)-lH-indol-3-yl)-N-(2-methoxypyridin- 4-yl)-2-oxoacetamide (16); [00292] To a solution of 5-methoxy-2-methyl- 1 H-indole (500 mg, 3.10 mmol) in N,N- dimethylformamide (200 mL) was carefully added a 60% dispersion in mineral oil of sodium hydride (248 mg, 6.20 mmol), followed by <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (785 mg, 3.10 mmol). The reaction mixture was stirred at 80 C for 48 hours after which it was quenched by the addition of saturated sodium bicarbonate solution (50 mL) extracted with dichloromethane (3 x 20 mL), dried (magnesium sulfate), filtered, and concentrated to a residue. Purification was achieved by silica gel chromatography using 5 to 20% of a 7:1 acetonitrile:methanol solution in dichloromethane over 60 minutes to afford 5-methoxy-2- methyl-l-(pyridin-4-ylmethyl)-l H-indole (0.324 g, 1.28 mmol, 41% yield) as a yellow solid. 1H NMR (400 MHz, CDC13) delta (ppm): 8.49 (dd, 2H), 7.05 (d, IH), 6.99 (d, IH), 6.83 (m, 2H), 6.76 (dd, IH), 6.29 (s, IH), 5.26 (s, 2H), 3.84 (s, 3H). LCMS: [ES]+ found 253.13.[00293] 2-(5-methoxy-2-methyl- 1 -(pyridin-4-ylmethyl)- 1 H-indol-3-yl)-N-(2- methoxypyridin-4-yl)-2-oxoacetamide was synthesized as a yellow solid in 7% yield starting from 5-methoxy-2-methyl-l-(pyridin-4-ylmethyl)-l H-indole using general procedure G. NMR MHz, CDC13) delta (ppm): 9.03 (br. s, IH), 8.55 (dd, 2H), 8.14 (d, IH), 7.80 (d, IH), 7.26 (d, IH), 7.15 (dd, IH), 7.07 (d, IH), 6.92 (d, 2H), 6.88 (dd, IH), 5.37 (s, 2H), 3.96 (s, 3H), 3.89 (s, 3H), 2.68 (s, 3H); LCMS: [ES]+ found 431.20. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25% | With hydrogenchloride; In methanol; at 20℃; for 0.0833333h; | Preparation of 6,7-dimethoxy-1-methyl-4-(pyridin-4-ylmethyl)isoquinolin-3-ol hydrochloride 11 To a solution of 6,7-dimethoxy-1-methylisoquinolin-3-ol CCH 18060 (197 mg, 899 mumol) in toluene (10 mL) in a 20 mL microwave vial equipped with a magnetic stirrer was added a 2 N aq. KOH solution (1.20 mL, 2.40 mmol) at RT followed by <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (250 mg, 988 mumol) and the mixture was stirred at 110 C. for 15 min under microwave irradiation. After cooling to RT, the mixture was diluted with H2O (5 mL) before extraction with CH2Cl2 (50 mL). The organic layer was washed with brine (10 mL), dried over Na2SO4, filtered and concentrated at 40 C. under vacuum. Purification by column chromatography (SiO2, eluent CH2Cl2:MeOH=100:0 to 90:10) gave 70 mg of 6,7-dimethoxy-1-methyl-4-(pyridin-4-ylmethyl)isoquinolin-3-ol as a yellow solid. This free base was dissolved in MeOH (5 mL) in a 25 mL round-bottomed flask equipped with a magnetic stirrer before addition of a 0.15 M HCl solution in MeOH (7 mL). The reaction mixture was stirred for 5 min at RT and concentrated at 40 C. under vacuum to afford 6,7-dimethoxy-1-methyl-4-(pyridin-4-ylmethyl)isoquinolin-3-ol hydrochloride 11 as a yellow solid (78 mg, 25% yield). MW: 346.81; Yield: 25%; Yellow solid; Mp ( C.): 158.2 (dec.). Rf (free base): 0.2 (cyclohexane:EtOAc=75:25). 1H-NMR (DMSO d6, delta): 2.88 (s, 3H, CH3), 3.89 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 4.75 (s, 2H, CH2), 7.03 (s, 1H, ArH), 7.32 (s, 1H, ArH), 7.90 (d, 2H, J=6.4 Hz, 2*ArH), 8.77 (d, 2H, J=6.4 Hz, 2*ArH). 13C-NMR (DMSO d6, delta): 17.8, 30.5, 55.8, 56.2, 100.9, 105.0, 109.0, 116.2, 126.6 (2*C), 137.5, 140.9 (2*C), 148.0, 149.7, 154.1, 155.8, 161.2. MS-ESI m/z (rel.int.): 311 ([MH]+, 100). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | General procedure: A suspension of 2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10a-c (1 mmol) in 10 mL of dry acetonitrile in a 50 mL two necked round-bottomed flask was mixed with cesium carbonate (8.5 mmol) and refluxed for 2 h. 2-(bromomethyl)pyridine hydrobromide, 3-(chloromethyl)pyridine hydrochloride or <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> (2 mmol) in acetonitrile (10 mL) was added portion-wise. Upon completion of the addition, the reaction mixture was refluxed for a further 30 min then evaporated off under reduced pressure. The residue was washed with 4 × 15 mL of CHCl3 and then filtered. The CHCl3 filtrate was evaporated off under reduced pressure and the resulting residue was triturated with minimal amount of diethyl ether to give the crude solid which was recrystallized from an appropriate solvent. 2-(Pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10a was allowed to react with <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> according to general procedure C. The crude solid was collected and recrystallized from toluene to give 11g (60% yield), mp 234 C. numax (KBr) 3067, 2927 (C-H), 1680 (C=O), 1630 (C=C), 1554 (C=N) cm-1; 1H NMR (DMSO-d6) delta 8.56 (bd, Jmeta = 2.2 Hz, 1H, H-2'), 8.52 (d, J = 5 Hz, 2H, H-9', H-11'), 8.49 (bdd, JH4',H5' = 4.5 Hz, JH4',H2' = 1.5 Hz, 1H, H-4'), 8.17 (d, J = 7.5 Hz, 1H, H-5), 7.58 (d, J = 5 Hz, 2H, H-8', H-12'), 7.44 (t, J = 7.5 Hz, 1H, H-7), 7.40 (m, 1H, H-5'), 7.32 (d, J = 5 Hz, 1H, H-6'), 7.20 (t, J = 7.5 Hz, 1H, H-6), 6.70 (d, J = 7.5 Hz, 1H, H-8), 5.30 (s, 2H, CH2-N); 13C NMR (DMSO-d6) delta 165.0 (C-4), 155.2 (C-2), 151.5 (C-8a), 148.6 (C-9', 11'), 148.2 (C-2'), 148.0 (C-4'), 147.7 (C-4'), 144.7 (C-7'), 137.2 (C-1'), 135.3 (C-7), 126.1 (C-5', 6'), 124.5 (C-5/C-8), 123.5 (C-8, C-12'), 116.8 (C-4a), 53.7 (CH2-N); (Found C, 69.45; H, 4.76; N, 17.05; C19H14N4O2, requires C, 69.08; H, 4.27; N, 16.96). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | General procedure: A suspension of 2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10a-c (1 mmol) in 10 mL of dry acetonitrile in a 50 mL two necked round-bottomed flask was mixed with cesium carbonate (8.5 mmol) and refluxed for 2 h. 2-(bromomethyl)pyridine hydrobromide, 3-(chloromethyl)pyridine hydrochloride or <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> (2 mmol) in acetonitrile (10 mL) was added portion-wise. Upon completion of the addition, the reaction mixture was refluxed for a further 30 min then evaporated off under reduced pressure. The residue was washed with 4 × 15 mL of CHCl3 and then filtered. The CHCl3 filtrate was evaporated off under reduced pressure and the resulting residue was triturated with minimal amount of diethyl ether to give the crude solid which was recrystallized from an appropriate solvent. 8-Methyl-2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10b was allowed to react with <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> according to General Procedure C. The crude solid was collected and recrystallized from toluene to give 11h (68% yield), mp 210 C. numax (KBr) 3056, 2918 (C-H), 1669 (C=O), 1627 (C=C), 1567 (C=N) cm-1; 1H NMR (DMSO-d6) delta 8.56 (bd, Jmeta = 2.2 Hz, 1H, H-2'), 8.52 (d, J = 5 Hz, 2H, H-9', H-11'), 8.49 (bdd, JH4',H5' = 4.5 Hz, JH4',H2' = 1.5 Hz, 1H, H-4'), 8.17 (d, J = 7.5 Hz, 1H, H-5), 7.58 (d, J = 5 Hz, 2H, H-8', H-12'), 7.44 (d, J = 7.5 Hz, 1H, H-7), 7.40 (m, 1H, H-5'), 7.32 (d, J = 5 Hz, 1H, H-6'), 7.20 (t, J = 7.5 Hz, 1H, H-6), 5.30 (s, 2H, CH2-N), 1.90 (s, 3H, 8-CH3); 13C NMR (DMSO-d6) delta 167.3 (C-4), 158.1 (C-2), 152.7 (C-8a), 150.9 (C-9', C-11'), 149.9 (C-2'), 149.5 (C-4'), 144.9 (C-7'), 137.2 (C-1'), 135.2 (C-7), 126.9 (C-6') 126.0 (C-5', C-6), 125.9 (C-8), 124.3 (C-5), 123.5 (C-8', C-12'), 118.1 (C-4a), 54.3 (CH2-N), 14.7 (CH3); (Found C, 69.57; H, 4.81; N, 16.09; C20H16N4O2, requires C, 69.76; H, 4.68; N, 16.27). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | General procedure: A suspension of 2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10a-c (1 mmol) in 10 mL of dry acetonitrile in a 50 mL two necked round-bottomed flask was mixed with cesium carbonate (8.5 mmol) and refluxed for 2 h. 2-(bromomethyl)pyridine hydrobromide, 3-(chloromethyl)pyridine hydrochloride or <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> (2 mmol) in acetonitrile (10 mL) was added portion-wise. Upon completion of the addition, the reaction mixture was refluxed for a further 30 min then evaporated off under reduced pressure. The residue was washed with 4 × 15 mL of CHCl3 and then filtered. The CHCl3 filtrate was evaporated off under reduced pressure and the resulting residue was triturated with minimal amount of diethyl ether to give the crude solid which was recrystallized from an appropriate solvent. 8-Phenyl-2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10c was allowed to react <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> according to general procedure C. The crude solid was collected and recrystallized from toluene to give 11i (60% yield), mp 265 C decomp. numax (KBr) 3056, 2918 (C-H), 1669 (C=O), 1627 (C=C), 1567 (C=N) cm-1; 1H NMR (DMSO-d6) delta 8.56 (bd, Jmeta = 2.2 Hz, 1H, H-2'), 8.52 (d, J = 5 Hz, 2H, H-9', H-11'), 8.49 (bdd, JH4',H5' = 4.5 Hz, JH4',H2' = 1.5 Hz, 1H, H-4'), 8.17 (d, J = 7.5 Hz, 1H, H-5), 7.58 (d, J = 5 Hz, 2H, H-8', H-12'), 7.44 (d, J = 7.5 Hz, 1H, H-7), 7.30-7.10 (m, 8H, H-5', H-6', H-6, and 5H of the 8-aryl group), 5.30 (s, 2H, CH2-N); 13C NMR (DMSO-d6) delta 166.7 (C-4), 157.7 (C-2), 150.5(C-C-8a), 149.1 (C-8', C-11'), 148.0 (C-2'), 147.9 (C-4'), 144.2 (C-7'), 136.5 (C-1'), 135.1 (C-7), 135.0 (C-6'), 134.7 (C-9), 128.8 (C-10, C-14), 128.30 (C11, C-13), 127.7 (C-12), 127.1 (C-5'), 125.9 (C-6), 125.0 (C-6'), 123.9 (C-5), 117.8 (C-4a), 54.3 (CH2-N); (Found C, 73.72; H, 4.46; N, 13.83; C25H18N4O2, requires C, 73.88; H, 4.46; N, 13.78). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | General procedure: A suspension of 2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10a-c (1 mmol) in 10 mL of dry acetonitrile in a 50 mL two necked round-bottomed flask was mixed with cesium carbonate (8.5 mmol) and refluxed for 2 h. 2-(bromomethyl)pyridine hydrobromide, 3-(chloromethyl)pyridine hydrochloride or <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> (2 mmol) in acetonitrile (10 mL) was added portion-wise. Upon completion of the addition, the reaction mixture was refluxed for a further 30 min then evaporated off under reduced pressure. The residue was washed with 4 × 15 mL of CHCl3 and then filtered. The CHCl3 filtrate was evaporated off under reduced pressure and the resulting residue was triturated with minimal amount of diethyl ether to give the crude solid which was recrystallized from an appropriate solvent. 8-Hydroxy-2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10d was allowed to react with <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> according to general procedure C. The crude solid was collected and recrystallized from toluene to give 13c (61% yield), mp 265-267 C decomp. numax (KBr) 3062, 2943(C-H), 1672 (C=O), 1624 (C=C), 1553 (C=N) cm-1; 1H NMR (DMSO-d6) delta 8.75 (bd, Jmeta = 2.2 Hz, 1H, H-2'), 8.60-8.50 (m, 4H, H-9', H-12', H-17', H-19'), 7.96(d, J = 7.5 Hz, 1H, H-5), 7.81 (m, 1H, H-4'), 7.70-7.60 (m, 2H, H-16', H-20'), 7.52 (d, J = 7.5 Hz, 1H, H-6'), 7.40-7.30 (m, 2H, H-8', H-13'), 7.20-7.10 (m, 2H, H-5', H-7), 6.93 (d, J = 7.5 Hz, 1H, H-6), 5.43 (s, 2H, CH2-O), 5.35 (s, 2H, CH2-N); 13C NMR (CDCl3) delta 167.8 (C-4), 158.4 (C-2), 155.7 (C-8a),153.4 (C-2'), 149.8 (C-9', C-11', C-17', C-19'), 149.3 (C-8), 144.9 (C-7'), 142.3(C-15, C-4'), 137.3 (C-1'), 135.6 (C-6'), 126.8 (C-5'), 124.3 (C-8', C-12'), 123.3 (C-7, C-16', C-20'), 1121.5 (C-5), 111.5 (C-4a), 110.1 (C-6), 71.6 (O-CH2), 56.6 (N-CH2); (Found C, 68.86; H, 4.50; N, 16.11; C25H19N5O3, requires C, 68.64; H, 4.38; N, 16.01). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | General procedure: A suspension of 2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10a-c (1 mmol) in 10 mL of dry acetonitrile in a 50 mL two necked round-bottomed flask was mixed with cesium carbonate (8.5 mmol) and refluxed for 2 h. 2-(bromomethyl)pyridine hydrobromide, 3-(chloromethyl)pyridine hydrochloride or <strong>[73870-24-3]4-(bromomethyl)-pyridine hydrobromide</strong> (2 mmol) in acetonitrile (10 mL) was added portion-wise. Upon completion of the addition, the reaction mixture was refluxed for a further 30 min then evaporated off under reduced pressure. The residue was washed with 4 × 15 mL of CHCl3 and then filtered. The CHCl3 filtrate was evaporated off under reduced pressure and the resulting residue was triturated with minimal amount of diethyl ether to give the crude solid which was recrystallized from an appropriate solvent. 7-Hydroxy-8-methyl-2-(pyridin-3-ylamino)-4H-benz[e]-1,3-oxazin-4-one 10f was allowed to react with <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> according to general procedure C. The crude solid was collected and recrystallized from toluene to give 15f (61% yield), mp 285 C decomp. numax (KBr) 3062, 2943(C-H), 1672 (C=O), 1624 (C=C), 1553 (C=N) cm-1; 1H NMR (DMSO-d6) delta 8.75 (bd, Jmeta = 2.2 Hz, 1H, H-2'), 8.60-8.50 (m, 4H, H-9', H-11', H-17', H-19'), 7.92 (d, J = 5.5 Hz, 1H, H-5), 7.82 (bdd, bdd, 1H, JH4',H5' = 4.5 Hz, JH4',H2' = 1.5 Hz, H-4'), 7.70-7.60 (m, 2H, H-16', H-20'), 7.52 (d, J = 5.5 Hz, 1H, H-6'), 7.40-7.30 (m, 2H, H-8', H-12'), 7.20-7.10 (m, 1H, H-5'), 6.92 (d, J = 7.5 Hz, 1H, H-6), 5.40 (s, 2H, CH2-O), 5.30 (s, 2H, CH2-N) 2.23 (s, 3H, 8-CH3); 13C NMR (CDCl3) delta 167.8 (C-4), 161.0 (C-7), 158.4 (C-2), 156.7 (C-8a), 155.8 (C-7'), 154.1 (C-15'), 153.4 (C-1'), 149.8 (C-9', C-11', C-17', C-19'), 149.3 (C-2'), 137.3 (C-4'), 135.6 (C-6'), 126.8 (C-5), 124.3 (C-8', C-12'), 123.3 (C-16', C-20'), 1121.5 (C-5'), 113.5 (C-8), 111.5 (C-4a), 110.1 (C-6), 71.6 (O-CH2), 56.6 (N-CH2), 8.3 (8-CH3); (Found C, 69.57; H, 4.31; N, 15.69; C26H21N5O3, requires C, 69.17; H, 4.69; N, 15.51). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75.8% | With N-ethyl-N,N-diisopropylamine; In acetonitrile; at 0 - 20℃; for 5h; | General procedure: Compound 6 (87mg, 0.5mmol), 2-(bromomethyl)-pyridine hydrobromide (126mg, 0.5mmol), N,N-diisopropylethylamine (DIPEA) (0.35ml, 2.0mmol) and CH3CN (10ml) were mixed together at 0C. The reaction was kept at rt for 5h. Once the reaction was completed (t.l.c. test) the solvent was concentrated under vacuum and the residue was dissolved in 20ml CH2Cl2. The organic phase was washed by saturated NaHCO3. The aqueous phase was extracted by CH2Cl2 (15ml×2). The organic phase was collected, dried with sodium sulphate and the solvent removed under vacuum to afford a residue which was purified by flash chromatograph (AcOEt/MeOH=1:1) to obtain pure compound 7a (100mg, yield: 75.8%) identified as ethyl ester. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With potassium tert-butylate; In N,N-dimethyl-formamide; at 20℃; for 48h; | Amide 67 (100mg, 0.36mmol) and potassium tert-butoxide (305mg, 2.71mmol) were added to DMF (5mL) in a 25mL round bottom flask. 4-(Bromomethyl)pyridine hydrobromide (136mg, 0.54mmol) was added to the reaction mixture in one portion. The reaction mixture was stirred at room temperature for 2 days, diluted with EtOAc (25mL) and filtered. The solvents were evaporated in vacuo, and the obtained syrup was extracted with EtOAc. The organic layer was washed with an aqueous sodium bicarbonate, brine, dried (MgSO4) and filtered. The volatiles were removed in vacuo, and the obtained syrup was purified on a Biotage KP-NH cartridge eluting with EtOAc/heptanes in different proportions to afford the target product as a light yellow glass. Yield: 118mg (89%). 1H NMR (500MHz, CDCl3) delta 8.48 (d, J=5.0Hz, 2H), 8.23 (s, 1H), 8.12 (d, J=7.7Hz, 1H), 7.49 (d, J=8.4Hz, 1H), 7.44 (t, J=7.7Hz, 1H), 7.29 (t, J=8.0Hz, 2H), 7.27-7.23 (m, 1H), 6.97 (d, J=5.4Hz, 2H), 5.48 (s, 2H), 3.58 (br. m, 4H), 1.79-1.67 (m, 3H), 1.63 (br. s, 3H). 13C NMR and DEPT (126MHz, CDCl3) delta 171.22 (C=O), 150.35 (CH), 145.93 (C), 140.90 (C), 140.86 (C), 127.88 (C), 126.69 (CH), 125.43 (CH), 123.04 (C), 122.91 (C), 121.40 (CH), 120.85 (CH), 120.26 (CH), 120.07 (CH), 108.96 (CH), 108.41 (CH), 45.66 (CH2), 24.78 (CH2). ESI: m/z 370.2 (M+H)+. HRMS calcd for C24H24N3O (M+H)+ 370.1919, found 370.1886. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With tetrabutylammomium bromide; potassium hydroxide; In dichloromethane; at 25℃; for 10h; | General procedure: After the compound 1o (700 mg, 1.68 mmol) was dissolved in dichloromethane (15 mL), potassium hydroxide (278 mg, 4.22 mmol) and tetrabutylammonium bromide (60 mg) were added thereto, and iodomethyl (0.525 mL, 8.435 mmol) was slowly added thereto at room temperature. This solution was stirred for 10 hours at 25C. Cooling water was added to the reaction material, and the result was adjusted to pH 5 to 6 using a 2N aqueous hydrochloric acid solution. After the organic layer was separated and taken, the aqueous layer was extracted once with dichloromethane, and the organic layers were combined, dried with anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was separated using silica gel column chromatography (normal-hexane/ethyl acetate=4/1) to give a pure target compound 1z (574 mg, 79%). 1H-NMR (300 MHz, CDCl3) delta 0.97 (s, 9H), 1.49 (s, 3H), 2.28 (s, 3H), 2.71 (s, 3H), 3.65 (s, 3H), 3.75 (s, 3H), 5.07 (s, 1H), 7.24 (m, 1H), 7.43 (m, 3H); MS (EI, m/e)=428 (M+). A target compound 10a (385 mg, 63%) was obtained by reacting the compound 1o (498 mg, 1.2 mmol) in thesame manner as in Step 1 of Example 1, except that <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> salt (2 equivalents) andpotassium hydroxide (3 equivalents) were used instead of iodomethyl. 1H-NMR (300 MHz, CDCl3) delta 0.99 (s, 9H), 1.52 (s, 3H), 2.12 (s, 3H), 2.68 (s, 3H), 3.68 (s, 3H), 5.10 (s, 1H),5.48 (AB-q, J=21.4Hz, 2H), 7.01 (d, J=5.8Hz, 2H), 7.28 (m, 1H), 7.42-7.48 (m, 3H), 8.51 (m, 2H); MS (EI, m/e)=505 (M+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | Sodium hydride {3.0 g, 125 mmol, 10 eq. (5.0 g of 60percent> NaH in oil)} was added to a solution of galeterone (1, 5.0 g, 12.9 mmoL, 1 eq.) in THF (80 mL) at 0°C under argon atmosphere. A white precipitate formed and after stirring for one minute, DMF (5.0 mL) was added and the reaction mixture was allowed to stir for 10 minutes at room temperature. The reaction mixture was placed at 0°C and lithium carbonate (5.0 g, 67.7 mmoL, 5 eq. ) was added, followed immediately by 4-(bromomethyl)pyridine hydrobromide (14, 10 g, 39.5 mmoL, 3 eq.) and the reaction mixture was allowed to stir at 0°C for 30 minutes. The reaction mixture was removed from 0°C and stirring continued at ambient temperature for 18 hours under argon atmosphere. The color of the reaction mixture changed from clear to dark red during the 18-hour period. After 18 hours, the reaction mixture was placed at 0°C, water (30 mL) was added to quench unreacted NaH, and the mixture was stirred for 10 minute. Volatile (THF) were removed in vacuo and water (70 mL) was added to the residue aqueous phase. The aqueous phase was extracted with ethyl acetate (EtOAc) (150 mL x 3). Ethyl acetate extract was washed with brine (80 mL x 2), dried with anhydrous Na2SO4 and concentrated in vacuo to give a dark red crude product. Purification by flash chromatography using 3percent MeOH/EtOAc as eluent afforded compound galeterone 3beta-pyridine methoxylate (3) as a white solid (3.78 g, 7.88 mmoL, 61percent), mp 177-179°C. Rf= 0.31 (5percent MeOH/EtOAc). | |
12% | With sodium hydride; In N,N-dimethyl-formamide; at 65℃; for 12h;Inert atmosphere; | To a solution of VN124-1 (0.1 g, 0.257 mmol), Sodium hydride (0.185 g, 7.7 mmol) and DMF (2 mL) at room temperature under argon added 4-(bromomethyl)pyridine hydrobromide (0.2 g, 0.772 mmol). The reaction heated to 65 °C, continued for 12 hr, cooled and then poured onto ice cold water, filtered and dried. Purification by FCC [petroleum ether/EtOAc (3:2)] gave VNPP414(A16) (15 mg, 12 percent): mp 166-67 °C; NMR (400 MHz, CDC13) delta 1.02 (s, 3 H, I8-CH3), 1.08 (s, 3 H, 19-CH3), 3.30 (m, 1 H, 3 -H), 4.59 ( s, 2 H, -CH2), 5.42 (d, J=4.89 Hz, 1 H, 6-H), 5.98 (br. s., 1 H, 16-H), 7.27 - 7.34 (m, 4 H, aromatic-Hs), 7.49 (d, J=5.14 Hz, 1 H, Ar7 FontWeight="Bold" FontSize="10" -H), 7.81 (d, J=4.40 Hz, 1 H, Ar- 6 FontWeight="Bold" FontSize="10" -H), 7.95 ( s, 1 H, Ar^'-H), 8.57 (d, J=4.65 Hz, 2 H, Ar-22, 62-Hs); 13C NMR (101 MHz, CDC13) 5 149.8, 148.2, 141.6, 141.0, 134.5, 124.0, 123.3, 122.4, 121.7, 121.2, 120.2, 111.1, 79.1, 68.3, 55.9, 50.5, 47.2, 39.1, 37.1, 37.0, 34.8, 31.1, 30.3, 30.3, 28.3, 20.6, 19.3, 16.0; HRMS calcd 502.2828 (C32H37N30)Na+, found 502.2834. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With triethylamine; In dichloromethane; at 0 - 20℃; | Et3N (1.69 mL, 12.15 mmol, 2.5 eq) was added dropwise to stirred solution of 2- (bromomethyl)pyridine hydrobromide (1.29 g, 5.10 mmol, 1.05 eq) in anhydrous DCM (10 mL). Methyl (tert-butoxycarbonyl)-L-cysteinate (1 mL, 4.86 mmol, 1 eq) was dissolved in 5 mL of DCM and added to 2-(bromomethyl)pyridine solution dropwise at 0 C. The resultant mixture was stirred overnight at room temperature. DCM was evaporated in vacuo and remaining residue was subjected to column chromatography on silica (Biotage SNAP KP-SIL 50 g cartridge, cHex/EtOAc). The solvents were evaporated to yield the desired compound as a yellow oil (1.08 g, 3.32 mmol, 68%). 1H NMR (400 MHz, CDC13) delta = 8.55 (d, J=5.5 Hz, 2 H), 7.25 (d, J=5.5 Hz, 2 H), 5.32 (d, J=7.0 Hz, 1 H, NH), 4.46 - 4.62 (m, 1 H, CH), 3.75 (s, 3 H, OCH3), 3.69 (s, 2 H, SCH2), 2.89 (dd, J=14.0, 4.5 Hz, 1 H, CHCHTT7), 2.78 (dd, J=14.0, 5.5 Hz, 1 H, CHCHJ ), 1.46 (s, 9 H, C(CH3)3) ppm, 13C NMR (126 MHz, CDC13) delta = 171.3, 155.2, 149.4, 148.2, 124.6, 80.5, 53.1, 52.8, 35.5, 33.9, 28.3 ppm. [a]20D = -34.0 (c = 0.3 in MeOH). HRMS (ESI- TOF) calcd for [M+Na+] : 349.1192, found: 349.1193. FT-IR vmax (neat): 3191, 2982, 1743, 1708, 1604, 1163, 740 cm"1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With caesium carbonate; In acetonitrile; at 60℃; for 6h; | To a solution of intermediate-2 (0.5 g, 1.98 mmol) in CH3CN (20 mL) were added cesium carbonate (1.58 g, 4.85 mmol) followed by 4-(bromomethyl)pyridine.HBr (0.73 g, 2.91 mmol) and stirred at 60C for 6h. After completion of the reaction, the reaction mixture was concentrated, diluted with water and extracted with EtOAc (200 mL X 2) twice. The combined organic layers were washed with water (200 mL), brine (100 mL), dried over sodium sulphateand concentrated under reduced pressure. The residue was purified on silica gel (100-200 mesh)to afford the titled product as off-white solid (0.52 g, 74%). 1H NMR (400 MHz, DMSO-d6) oe8.52 (d, J=4.4 Hz, 2H), 7.3 1-7.30 (m, 3H), 6.89 (s, 1H), 5.26 (s, 2H), 4.78 (s, 2H), 3.66 (s, 3H). |
74% | With caesium carbonate; In acetonitrile; at 60℃; for 6h; | Intermediate-28 RRN 198Synthesis of 7-bromo-6-methoxy-4-(pyridin-4-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one (Method-A) (0196) (0197) To a solution of intermediate-2 (0.5 g, 1.98 mmol) in CH3CN (20 mL) were added cesium carbonate (1.58 g, 4.85 mmol) followed by 4-(bromomethyl)pyridine.HBr (0.73 g, 2.91 mmol) and stirred at 60 C. for 6 h. After completion of the reaction, the reaction mixture was concentrated, diluted with water and extracted with EtOAc (200 mL×2) twice. The combined organic layers were washed with water (200 mL), brine (100 mL), dried over sodium sulphate and concentrated under reduced pressure. The residue was purified on silica gel (100-200 mesh) to afford the titled product as off-white solid (0.52 g, 74%). 1H NMR (400 MHz, DMSO-d6) delta 8.52 (d, J=4.4 Hz, 2H), 7.31-7.30 (m, 3H), 6.89 (s, 1H), 5.26 (s, 2H), 4.78 (s, 2H), 3.66 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With caesium carbonate; In N,N-dimethyl-formamide; at 20℃; for 1h; | The 4-(4-chlorophenyl)-1-(2-methoxyethyl)-6-methyl-2-oxo-3,4-dihydropyridine-5-carboxylic acid (example 74, 75 mg, 0.23 mmol) was dissolved in anhydrous DMF (1 mL) then cesium carbonate (114 mg, 0.35 mmol) and <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (63 mg, 0.25 mmol) were added. The reaction mixture was stirred for 1 h at RT. The solvent was removed under reduced pressure. The residue was dissolved in EtOAc and water. The aqueous phase was extracted 3 times with EtOAc. The organic layers were assembled, washed with brine and dried over MgS04. The solvent was removed under reduced pressure to give the desired 4- p y r i d y l m e t h y l 4-(4-chlorophenyl)-1 -(2-methoxyethyl)-6-methyl-2-oxo-3,4-dihydropyridine-5- carboxylate as a white powder (95 mg, 99 %). 1 H N MR (300 MHz, CDCI3) delta 2.58 (s, 3H), 2.67 (dd, J = 15.7, 2.2 Hz, 1 H), 2.88 (dd, J = 15.7, 7.5 Hz, 1 H), 3.26 (s, 3H), 3.29-3.36 (m, 1 H), 3.41 (dt, J = 9.9, 4.0 Hz, 1 H), 3.71 (ddd, J = 14.5, 8.7, 3.7 Hz, 1 H), 4.08-4.17 (m, 2H), 4.96 (d, J = 14.1 Hz, 1 H), 5.1 1 (d, J = 14.1 Hz, 1 H), 6.87 (d, J = 5.2 Hz, 2H), 7.06 (d, J = 8.3 Hz, 2H), 7.18 (d, J = 8.3 Hz, 2H), 8.41 (d, J = 5.2 Hz, 2H). MS [M+H]+ 415. HRMS : calcd for C22H24N204CI, [M+H]+ 415.1425, found 415.1424. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; for 1h; | General procedure: Potassium carbonate (0.145 mmol) was added to a solution of the appropriate amide (0.048 mmol) and an alkyl halide (0.058 mmol), in DMF (300 muL) and stirred at 80C for 4 h. The reaction mixture was added to water (5mL) and extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product was purified by flash column chromatography to give the desired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
24% | The mixture of 15G (350 mg, 0.678 mmol, 1 .0 eq) and 2C03 (562 mg, 4.07 mmol, 6.0 eq) in DMF (5 mL) was stirred at room temperature for 10 minutes, followed by the addition of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (51 5 mg, 2.04 mmol, 3.0 eq). The resulting mixture was stirred at room temperature for 16 hours. The reaction was monitored by LC-MS. After filtration through a short celite pad, the filtrate was concentrated under reduced pressure and the residue was purified by flash chromatography on silica (PE/EA = 10: 1 -0: 1 ) to give compound 28A (100 mg, 24%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | With caesium carbonate; In acetonitrile; at 150℃; for 3h;Microwave irradiation; | (0389) Obtained according to the general method described previously. (0390) Reagents: 3-Phenyl-4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazoline (0.80 mmol, 0.200 g), 4-bromomethylpyridine hydrobromide (1.2 mmol, 303.5 mg), Cs2CO3 (0.8145 g). (0391) The reaction conditions were: 3 hours under microwave radiation at 150 C. (0392) Purification was carried out by means of silica gel column chromatography (hexane/ethyl acetate, in a ratio of 10:1 by volume). (0393) The yield obtained was: a white solid (130 mg, 47%). P.f.: 178.0-179.0 C. 1H-RMN (400 MHz, CDCl3) delta: 8.53 (d, 2H, J=6.1 Hz), 8.24 (dd, 1H, J=7.9, 1.5 Hz), 7.81-7.71 (m, 1H), 7.65-7.58 (m, 1H), 7.57-7.39 (m, 4H), 7.38 (d, 2H, J=6.1 Hz), 7.33-7.28 (m, 2H), 4.37 (s, 2H). 13C-RMN (100 MHz, CDCl3) delta: 161.6, 155.8, 149.5, 147.5, 147.2, 135.5, 134.8, 130.2, 129.8, 129.1, 127.4, 126.2, 126.1, 124.4, 119.9, 35.2, purity analysed by HPLC 99%. EM (m/z): 346 [M+H]+. Elemental analysis (C20H15N3OS): theoretical % C, 69.54; % H, 4.38; % N, 12.17; % S, 9.28. observed % C, 69.38; % H, 4.45; % N, 12.06; % S, 9.30. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
24% | 1001911 Into an 8-mL vial, was placed a solution of methyl 2-oxospiro[pyrrolidine-3,2?- thiochromane]-6?-carboxylate 1,1-dioxide (100 mg, 0.32mmol, 1 equiv) in DMF (3 mL). This was followed by the addition of NaH (60% dispersion in oil, 65 mg, 2.71 mmol, 5 equiv) at 0 C over 10 mm. To this was added 4-(bromomethyl) pyridine hydrobromide (163 mg, 0.64 mmol, 2 equiv). The resulting mixture was stirred for 18 h at room temperature. The reaction was then quenched by the addition of NH4C1 (aq.). The resulting solution was extracted with 2x20 mL of EtOAc and the aqueous layers combined. The pH of the aqueous layers was adjusted to 4 with iN aq. HC1. The resulting solution was extracted with 3x20 mL of CH2C12, dried over anhydrous magnesium sulfate, filtered, and concentrated under vacuum to give 30 mg (24% yield) of the title compound as a light brown oil which was used in the next step without purification. MS:(ES, m/z): 387 [M+H]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13% | Example 74 7-(4-fluorophenyl)-3-methyl-5-(pyridin-4-ylmethyl)[1,2]oxazolo[4,5-d]pyridazin-4(5H)-one To a solution of 7-(4-fluorophenyl)-3-methyl[1,2]oxazolo[4,5-d]pyridazin-4(5H)-one (Example 19, 100 mg, 0.408 mmol) in N,N-dimethylformamide (2 mL) was added NaH (14.68 mg, 0.612 mmol). The mixture was stirred at room temperature for 15 minutes, and then <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (124 mg, 0.489 mmol) was added. The solid was collected by filtration and washed with water and methanol to give the titled compound (18 mg, yield 13%). 1H NMR (400 MHz, DMSO-d6) delta ppm 8.09-8.06 (m, 2H), 7.68-7.65 (m, 2H), 7.45-7.41 (m, 2H), 7.22 (m, 1H), 5.41 (s, 2H), 3.84 (s, 3H), 2.59 (s, 3H); MS (APCI+) m/z 434.0 (M+H)-. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
56% | j00411j To a solution of compound MFW2464 (300 mg, 1,91 mrnol) in EtOH (5 ml) was added NaBFI4 (144 mg, 3.82 mmoi) room temperature. The mixture was stirred for Ih, and then acetone (3 ml) was slowly introduced. After lb, a solution of 4-{brornomethyl)pyridine hydrobromide (483 mg, 1.91 mmoi) in EtOH (3 ml) was added. The resulting dark reaction mixture was heated to reflux for lh, and was then cooled and concentrated in vacuo. The residue was partitioned between EtOAc and brine. The organic phase was separated, dried (MgSO4), and concentrated in vacuo to give a crude solid which was triturated with diethyl ether/hexane to provide compound MFW34464 (240 ing, 56%) as solid LCMS (miz): 224 [M + Fl] +. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | CIS-8-(dimethylamino)-8-phenyl-1-(p-tolylsulfonyl)-1,3-diazaspiro[4.5]decan-2-one (INT-1028) (200 mg, 0.47 mmol, 1 equiv.) was dissolved in DMF (3.6 mL) under argon atmosphere and the solution was cooled down to 0C. Sodium hydride (60wt% in mineral oil, 2.1 equiv., 0.98 mmol, 39 mg) was added and the reaction mixture was stirred at RT for 15 min. 4-(Bromomethyl)pyridine hydrobromide (1.05 equiv., 0.49 mmol, 124 mg) was added at 0C. The reaction mixture was stirred overnight at RT, then quenched with sat. aq. NaHCO3 (2 mL) and water (2 mL) and extracted with EtOAc (2x15 mL). The combined organic extract was washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (100% acetonitrile) to yield CIS-8-(dimethylamino)-3-(4-methoxybenzyl)-8-phenyl-1-tosyl-1,3-diazaspiro[4.5]decan-2-one (112 mg, 46%). Mass: m/z 519.2 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | General procedure: A suspension of 8-bromo-7-hydroxy-2-morpholino-1,3-benzoxazine 13 (1.5 mmol) in 15 mL of dry acetonitrile in a 50 ml two necked round-bottomed flask was mixed with potassium carbonate (9 mmol) and then the mixture was refluxed for 2 hours. 2-(Bromomethyl)-pyridine-hydrobromide, 3-(chloro-methyl)-pyridine hydrochloride or 4-(bromo-methyl)-pyridine hydrobromide (3 mmol) was added slowly. Upon completion of the addition the reaction mixture was reflux for further 2 hours. The reaction mixture was evaporated off under reduced pressure. The residue was washed with 4 x 15 mL of CHCl3 , then filtered. The CHCl3 filtrate was evaporated off under reduced pressure, the resulting residue was triturated with minimal amount of diethyl ether to give the crude solid. The resulting residue was triturated with diethyl ether and the resulted solid was purified by the applicable method. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.53% | With lithium hexamethyldisilazane; In tetrahydrofuran; at -78℃; for 2h; | Step 3 tert-butyl 2-(4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl)-3-(pyridin-4-yl)prop ionate 185e Compound 185c (200 mg, 533.39 mumol) and <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> 185d (269.92 mg, 1.07 mmol, prepared by a known method disclosed in "") were dissolved in 10 mL of tetrahydrofuran. The reaction solution was cooled to -78C, dropwise added with lithium bis(trimethylsilyl)amide solution (3.2 mL, 3.2 mmol) , and stirred for 2 hours. At -78C, the reaction solution was slowly added with 10 mL of water to quench the reaction, and then added with 10 mL of saturated sodium chloride solution. The reaction solution was naturally warmed up to room temperature, and extracted with ethyl acetate (20 mL * 3). The phases were combined, washed with saturated sodium chloride solution (20 mL * 2), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressur, and the resulting residue was purified by silica gel column chromatography with elution system A to obtain the title compound 185e (240 mg, yield: 96.53%). |
tert-Butyl 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(pyridin-4-yl)propanoate (Racemate) To a solution of 2.25 g (6.00 mmol) of tert-butyl [4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]acetate in 48 ml of tetrahydrofuran under argon and at -78 C. were added dropwise 15.01 ml (1.0M in THF, 2.5 eq.) of lithium bis(trimethylsilyl)amide, and the mixture was stirred for 20 min. Subsequently, 2.13 g (8.40 mmol, 1.4 eq.) of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> were added. The resulting reaction mixture was stirred at -78 C. for another 30 min and at RT for another 1.5 h. Saturated aqueous ammonium chloride solution was added to the reaction mixture. After phase separation, the aqueous phase was extracted with ethyl acetate. The combined organic phases were washed with saturated aqueous sodium chloride solution. The organic phase was dried (sodium sulphate), filtered and concentrated under reduced pressure. The crude product was then purified by means of normal phase chromatography (eluent: cyclohexane/ethyl acetate (0-100%) mixtures). Yield 2.0 g (87% purity, 62% of theory) LC/MS [Method 1]: Rt=0.76 min; MS (ESIpos): m/z=466 (M+H)+, 1H-NMR (400 MHz, DMSO-d6): delta [ppm]=8.46-8.37 (m, 2H), 7.97 (d, 1H), 7.71 (dd, 1H), 7.66 (d, 1H), 7.26-7.13 (m, 3H), 6.45 (s, 1H), 5.36 (t, 1H), 3.53-3.40 (m, 5H), 1.40 (s, 9H). | ||
[0606] To a solution of 2.25 g (6.00 mmol) of tert-butyl [4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1 (2H)-yl]acetate in 48 ml of tetrahydrofuran under argon and at -78 C. were added dropwise 15.01 ml (1.OM in THF, 2.5 eq.) of lithium bis(trimethylsilyl)amide, and the mixture was stirred for 20 mm. Subsequently, 2.13 g(8.4Ommol, 1.4 eq.) of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> were added. The resulting reaction mixture was stirred at -78 C. for another 30 mm and at RT for another 1.5 h. Saturated aqueous ammonium chloride solution was added to the reaction mixture. After phase separation, the aqueous phase was extracted with ethyl acetate. The combined organic phases were washed with saturated aqueous sodium chloride solution. The organic phase was dried (sodium sulphate), filtered and concentrated under reduced pressure. The crude product was then purified by means of normal phase chromatography (eluent: cyclohexane/ethyl acetate (0-100%) mixtures). Yield 2.0 g (87% purity, 62% of theory)[0607] LC/MS [Method 1]: R=0.76 mm; MS (ESIpos):mlz=466 (M+H),j0608] ?H-NMR (400 MHz, DMSO-d5): oe [ppm]=8.46-8. 37 (m, 2H), 7.97 (d, 1H), 7.71 (dd, 1H), 7.66 (d, 1H),7.26-7.13 (m, 3H), 6.45 (s, 1H), 5.36 (t, 1H), 3.53-3.40 (m, 5H), 1.40 (s, 9H). |
tert-Butyl 2-[4-(5 -chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3 -(pyridin-4-yl)propanoate (racemate) To a solution of 2.25 g (6.00 mmol) of tent-butyl [4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]acetate in 48 ml of tetrahydrofuran under argon and at -78 C. were added dropwise 15.01 ml (1.0M in THF, 2.5 eq.) of lithium bis(trimethylsilyl)amide, and the mixture was stirred for 20 min. Subsequently, 2.13 g (8.40 mmol, 1.4 eq.) of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> were added. The resulting reaction mixture was stirred at -78 C. for another 30 min and at RT for another 1.5 h. Saturated aqueous ammonium chloride solution was added to the reaction mixture. After phase separation, the aqueous phase was extracted with ethyl acetate. The combined organic phases were washed with saturated aqueous sodium chloride solution. The organic phase was dried (sodium sulphate), filtered and concentrated under reduced pressure. The crude product was then purified by means of normal phase chromatography (eluent: cyclohexane/ethyl acetate (0-100%) mixtures). Yield 2.0 g (87% purity, 62% of theory) LC/MS [Method 1]: Rt=0.76 min; MS (ESlpos): m/z=466 (M+H)+, 1H-NMR (400 MHz, DMSO-d6): delta[ppm]=8.46-8.37 (m, 2H), 7.97 (d, 1H), 7.71 (dd, 1H), 7.66 (d, 1H), 7.26-7.13 (m, 3H), 6.45 (s, 1H), 5.36 (t, 1H), 3.53-3.40 (m, 5H), 1.40 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With potassium carbonate; In N,N-dimethyl-formamide; | The compound [84] (4.70 g, 16.0 mmol), potassium carbonate (3.31 g, 24.0 mmol) and dimethylformamide (DMF) (50 g) were added to a 200 L four-necked flask and a solution of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (4.45 g, 17.6 mmol) in DMF (10 g). After completion of the reaction, the reaction solution was poured into pure water (600 g) and extracted three times with ethyl acetate (150 g). Next, the organic layer was washed with saturated sodium bicarbonate and saturated brine, and the organic layer was dried over magnesium sulfate. The solvent was then distilled off to remove the solvent and the crude material was recrystallized from methanol to give 4.4 g of the compound [86] (yield 72%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25% | With potassium carbonate; In N,N-dimethyl-formamide; at 60℃; for 4h; | To a solution of E12 (100 mg, 0.21 mrnol) in DMF (2 mL) is added 4 (broniornethvl)pyridine hydrobromide (104 mg. 0.42 mmol) and potassium carbonate (171 mg, 1 .24 mmol), Afer stirring at 60 C for 4 hours, the mixture is concentrated and purified by prepTLC (MeOH:DCM == 1:20) to give 261 as ayeliow solid (3() mg, 25% yield). (MS:[MH-HJ 575.1) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | To a solution of potassium carbonate (84 mg, 0.605 mmol) in DMF (0.5 mL) was added ethyl acetoacetate (0.08 mL, 0.605 mmol). After stirring at rt for 2 h, 3-methoxyophenyl isothiocyanate (0.08 mL, 0.6053 mmol) was added at 0 C. Then, the mixture was stirred at 60 C for 2 h before addition of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (153 mg, 0.6053 mmol). The reaction mixture was stirred at 0 C and extracted with ethyl acetate. The organic layer was dried over anhydrous Na2SO4, filtered and evaporated. The resulting crude residue was purified by column chromatography (ethyl acetate/Hex 20%) to give product (173 mg, 80% yield) as a yellow liquid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With potassium carbonate; In acetone; at 20℃; for 18h; | To 2-bromo-lH-imidazole (73.5 mg, 0.5 mmol), 4-(bromomethyl)pyridine hydrobromide (139 mg, 0.550 mmol) and potassium carbonate (207 mg, 1.500 mmol) was added acetone (15 mL). This mixture was stirred for 18 h at RT. The solvent was then removed in vacuo yielding a brown residue. This residue was then partitioned between ethyl acetate (35 mL) and water (35 mL) and the phases separated. The aqueous phase was then extracted twice with ethyl acetate (2x35 mL), the organics combined and then dried using a hydrophobic frit. The solvent was then removed in vacuo yielding a dark brown oil determined to be the title compound (108 mg, 0.454 mmol, 91%). LCMS (System B): tRET = 0.57 min; MH+ 238, 240. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | To a suspension of intermediate A (970 m~J, 2.59 mmol, 1 equiv.) and activated powdered 4Amolecular sieves (1.0 g) in anhydrous DMF (8 ml) was added dried cesium hydroxide monohydrate (1.09 g, 6.47 mmol, 2.5 equiv.) and the mixture was vigorously stirred for 30min. 4-(Bromo-methyl)-pyridine hydrobromide (721 mg, 2.85 mmol, 1.1 equiv.) was added tothe brown suspension, and the reaction was allowed to stir at room temperature for 12 h. Thereaction mixture was filtered to remove undissolved solids and washed wiU1 eU1yl acetate (2 x20 mL). H1e filtrate was concentrated, and U1e residue was extracted wiU1 1 N NaOH and ethyl acetate (4 x 20mL).The combined organic layers were dried over Na2S04, filtered, and evaporated. The resultingcrude mixture was purified by column chromatography (Si02; n-hexane:ethyl acetate- (1 :1) +5vol% NEb) to afford the product (796 mg, 1.71 mmol, 66%) as a yellow oil.1H-NMR: (400MHz, CDCb): 1.49 (s, 9H), 3.53 (d, J::: 12.9 Hz, 1H), 3.64 (d, J::: 13.3 Hz, 1H), 3.72 (d, J::: 14.7 Hz, 1H), 3.84 (m, 3H), 6.70-6.75 (m, 2H), 7.03-7.09 (m, 4H), 7.17-7.24 (m,9H), 8.52 (d, J = 4.8 Hz, 2H).2013C-NMR: (400 MHz, CDCb): 29.6, 34.8, 50.0, 50.9, 67.5, 68.4, 118. 4, 123.0, 123.3, 126.1,126.7, 127.6, 127.7, 127.8, 127.9, 128.4, 128.5, 137.0, 138.9, 139.8, 149.1, 149.9, 156.9 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | To a solution of 2-ethyl-4-methyl-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)oxazole-5-carboxamide (0.050 g, 0.130 mmol) in anhydrous dimethylformamide (3 mL) in a flamed dried flask under argon atmosphere at 0 C. was added sodium hydride (60% in mineral oil, 0.018 g, 0.458 mmol) was added in one portion. The reaction was stirred for 10 min at 0 C. then <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (0.022 g, 0.131 mmol) was added via syringe. The mixture was then stirred for 2 hours at room temperature. After consumption of starting material, the reaction mixture was quenched with saturated ammonium chloride (25 mL) and extracted with ethyl acetate (2*25 mL). The combined organics were washed once with saturated sodium bicarbonate (50 mL) and dried over anhydrous sodium sulfate. The concentrated residue was purified by flash chromatography over silica gel using 95:5 dichloromethane/methanol to give 2-ethyl-4-methyl-N-(4-(2-oxo-1-(pyridin-4-ylmethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)oxazole-5-carboxamide (0.037 g, 60%) as a white solid. 1H NMR (400 MHz, DMSO-d): delta 12.59 (s, 1H), 8.49 (dd, 1H, J=4.0, 1.6 Hz), 7.83 (d, 1H, J=2.0 Hz), 7.68 (dd, 1H, J=8.4, 2.0 Hz), 7.58 (s, 1H), 7.24 (dd, 1H, J=4.4, 1.6 Hz), 6.89 (d, 1H, J=8.8 Hz), 5.20 (s, 2H), 3.04 (m, 2H), 2.81 (q, 2H, J=7.2 Hz), 2.77 (m, 2H), 2.41 (s, 3H), 1.32 (t, 3H, J=7.2 Hz). MS (ESI): Calcd. for C25H23N5O3S: 473, found 474 (M+1)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.6% | With caesium carbonate; In N,N-dimethyl-formamide; at 20℃; | (Example 1) Synthesis of 1-(2-methoxy-5-((pentafluorosulfanyl)phenyl)-3-(2-(pyridin-4-ylmethoxy)benzyl)urea: A solution of the compound of Reference Example 1 (2.0 g, 5.0 mmol), <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (1.52 g, 6.0 mmol) and cesium carbonate (4.1 g, 13 mmol) in N,N-dimethylformamide (10 mL) was stirred overnight at room temperature, and water was subsequently added to the reaction solution, and the obtained solution was extracted with diethyl ether. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and then concentrated under vacuum. The obtained crude product was purified by silica gel column chromatography (ethyl acetate, Rf = 0.32) to obtain a compound of interest (140 mg, 5.6%) (hereinafter referred to as the compound of Example 1) as a white solid. 1H-NMR (400 MHz, CDCl3) delta (ppm): 3.87 (3H, s), 4.58 (2H, d, J = 4.0 Hz), 5.16 (2H, s), 6.81 (2H, m), 6.88 (1H, d, J = 8.0 Hz), 7.00 (1H, t, J = 8.0 Hz), 7.35 - 7.40 (4H, m), 8.62 (1H, dd, J = 8.0, 4.0 Hz), 8.69 (1H, d, J = 4.0 Hz). MS(ESI) [M + H]+: 490. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | Into a round bottomed flask equipped with a nitrogen inlet and a magnetic stir bar, (4- (lH-benzo[d]imidazol-2-yl)piperidin-l-yl)(3,5-dimethoxyphenyl)methanone (366 mg, 1 mmol), NaH (60 % in oil, 87 mg, 2.18 mmol) and 2.6 mL DMF were added and stirred at room temperature for 2 hours. Solution of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (379 mg, 1.5 mmol) in 0.2 mL of DMF was then slowly added to the above solution. The reaction mixture was then allowed to stir at 80 C for 4 hours. Water was then added to the reaction mixture and stirred for 15 minutes. The sticky solid formed was filtered and washed with water. The solid was purified using the combifiash purification system with 0-5 % MeOH in CH2Cl2 to give 301 mg (66 %) of white solid as the pure and desired compound. (0496) XH NMR (400 MHz, Chloroform-i ) delta 8.58 (d, J = 6.0 Hz, 2H), 7.83 (d, J= 7.9 Hz, 1H), 7.40 - 7.30 (m, 1H), 7.26 (td, J = 7.6, 1.1 Hz, 1H), 7.16 (d, J= 8.1 Hz, 1H), 6.94 (d, J = 6.1 Hz, 2H), 6.55 (d, J= 2.3 Hz, 2H), 6.50 (t, J = 2.3 Hz, 1H), 5.43 (s, 2H), 4.81 (bs, 1H), 4.16 - 3.89 (m, 1H), 3.82 (d, J = 0.9 Hz, 6H), 3.02 (ddt, J = 11.4, 7.5, 3.8 Hz, 2H), 2.93 (bs, 1H), 2.21 - 2.08 (m, 2H), 1.96 (s, 1H), 1.86 (s, 1H). 1 C NMR (101 MHz, Chloroform-c ) delta 170.06, 160.91, 156.50, 150.64, 144.94, 137.74, 134.80, 123.00 (d, J = 33.5 Hz), 120.74, 119.79, 109.39, 104.58, 101.75, 55.53, 36.72, 36.51, 34.52, 31.45. LCMS: Expected: 457 (M+H)+; Found: 457. HRMS:- Found: 457.22397 (M+H)+; Theoretically = 457.22342. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45.8% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; for 0.5h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23.1% | With potassium carbonate; In N,N-dimethyl-formamide; at 40℃; for 0.666667h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With potassium carbonate; In N,N-dimethyl-formamide; at 40℃; for 1h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
33.6% | With potassium carbonate; In N,N-dimethyl-formamide; at 40℃; for 2h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46.1% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; for 0.25h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
26.3% | With potassium carbonate; In N,N-dimethyl-formamide; at 60℃; for 2h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41.5% | With potassium carbonate; In N,N-dimethyl-formamide; at 60℃; for 4h; | General procedure: Compounds 20-26 (1 equiv.) were dissolved in DMF followed by the addition of potassium carbonate (1 - 3 equiv.) and the corresponding benzyl- or pyridinylderivate (1-2 equiv.). This mixture was allowed to stir at various temperatures and timespans, all of which are further specified at the corresponding compounds reported below. The crude product was then purified by either normal phase or reversed phase flash chromatography to yield compounds 30-36 and 40-46. The exact conditions of these purifications are reported below for each compound individually. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65.4% | With sodium hydride; In tetrahydrofuran; mineral oil; for 24h;Inert atmosphere; Reflux; | General procedure: To a THF solution (25mL) of compound 21 (84.5mg, 0.06mmol) were successively added NaH (60% oil suspension, 85mg) and <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (84.5mg, 0.338mmol) under argon, and the mixture was heated under reflux for 24h. After being allowed to cool to room temperature, the resulting mixture was quenched with MeOH (5mL) and diluted with CHCl3 (50mL). An organic phase separated was washed successively with saturated aqueous NH4Cl and water, dried over MgSO4, and evaporated to dryness. And the mixture was purified by silica gel column chromatography (SiO2, CHCl3/MeOH=98:2), followed by reprecipitation from THF/MeOH, to allow isolation of 2 as yellow solid (42mg, 44%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
15.3% | With potassium carbonate; In N,N-dimethyl-formamide; at 80℃; for 3.5h; | [00385] To a mixture of 53-1 (60 mg, 0.187 mmol, 1.00 eq) and 53-2 (85 mg, 0.336 mmol, 1.80 eq, HBr) in DMF (3 mL) was added K2C03 (100 mg, 0.723 mmol, 3.87 eq) in one portion at 25C. The mixture was stirred at 80 C for 3.5 h. LCMS showed the starting material was consumed completely and one main peak with the desired MS was detected. TLC showed one new spot was formed. The reaction mixture was extracted with EtOAc (40 mL) and washed with brine (30 mL*4). The organic layer was dried with anhydrous Na2S04, filtered, and concentrated under vacuum. The residue was purified by flash silica gel chromatography and then by prep-HPLC (basic condition) to provide the title compound (11.77 mg, 28.5 umol, 15.3% yield). LCMS (ESI): RT = 1.120 min, mass calc. for C20Hi5F3N6O 412.13, m/z found 413.0[M+H]+. 1HNMR (400MHz, DMSO-i_) 58.65- 8.55 (m, 3H), 8.01 (d, J=8.00 Hz, 1H), 7.47 - 7.37 (m, 2H), 7.33 (br d, J=5.20 Hz, 2H), 7.30 - 7.24 (m, 2H), 7.23- 7.17 (m, 2H), 7.06 (t, J=6.80 Hz, 1H), 6.12 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
38.2% | With potassium carbonate; In N,N-dimethyl-formamide; at 80℃; for 16h; | [00367] To a mixture of 41-1 (60 mg, 0.197 mmol, 1.00 eq) and 41-2 (80 mg, 0.316 mmol, 1.61 eq, HBr) in DMF (2.5 mL) was added K2C03 (100 mg, 0.723 mmol, 3.68 eq) in one portion at 25C. The mixture was stirred at 80 C for 16 h. The reaction was monitored by LCMS. The reaction mixture was diluted with water (15 mL) and extracted with EtOAc (20 mL * 3). The combined organic layers were dried with anhydrous Na2S04, filtered and concentrated under vacuum. The residue was purified by flash silica gel chromatography to provide the title compound (31.32 mg, 75 umol, 38.2% yield). LCMS (ESI): RT = 1.126 min, mass calcd. for C2oHi5F3N6, 396.13 m/z found 397.0[M+H]+ and 377.0[M+H-20]+.1HNMR (400MHz, DMSO-i_) 58.71 (s, 1H), 8.61- 8.53 (m, 2H), 8.03- 7.97 (m, 1H), 7.56 - 7.48 (m, 4H), 7.32- 7.26 (m, 2H), 7.24- 7.17 (m, 1H), 7.11 (d, J=8.50 Hz, 2H), 6.09 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20 - 50℃; for 19h;Inert atmosphere; | General procedure: DIPEA (778 muIota, 4.46 mmol) was added dropwise to a stirred solution of N-(2-hydroxyethyl)-4- (2H-tetrazol-5-yl)benzenesulfonamide (300 mg, 1.1 14 mmol, Intermediate 17') and 2- (bromomethyl)tetrahydro-2H-pyran (285 muIota, 2.228 mmol, commercial source: Aldrich) in N,N- Dimethylformamide (DMF) (3714 muIota) at rt under nitrogen. The mixture was stirred at rt for 3 days. As starting material remained, it was stirred at 70 C overnight. The mixture was concentrated under reduced pressure. The crude compound was purified by flash column chromatography (silica; EtOAc-cyclohexane from 0/100 to 50/50). The desired fractions were collected and concentrated in vacuo to obtain the product as a racemic mixture N-(2- hydroxyethyl)-4-(2-((tetrahydro-2H-pyran-2-yl)methyl)-2H-tetrazol-5-yl)benzenesulfonamide (49 mg, 0.133 mmol, 28%). NMR (400 MHz, Acetone-d6) delta 7.84-7.78 (m, 2H), 7.56-7.50 (m, 2H), 7.33 (t, J = 5.9 Hz, 1 H), 4.37-4.32 (m, 2H), 4.25 (t, J = 5.6 Hz, 1 H), 3.50-3.44 (m, 1 H), 3.38-3.32 (m, 1 H), 2.94-2.90 (m, 2H), 2.86-2.80 (m, 1 H), 2.41-2.37 (m, 2H), 1.40-1.25 (m, 2H), 1.12-0.85 (m, 4H). MS m/z [M-H]"= 366.2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7% | With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20 - 50℃; for 36h;Inert atmosphere; | General procedure: DIPEA (778 muIota, 4.46 mmol) was added dropwise to a stirred solution of N-(2-hydroxyethyl)-4- (2H-tetrazol-5-yl)benzenesulfonamide (300 mg, 1.1 14 mmol, Intermediate 17') and 2- (bromomethyl)tetrahydro-2H-pyran (285 muIota, 2.228 mmol, commercial source: Aldrich) in N,N- Dimethylformamide (DMF) (3714 muIota) at rt under nitrogen. The mixture was stirred at rt for 3 days. As starting material remained, it was stirred at 70 C overnight. The mixture was concentrated under reduced pressure. The crude compound was purified by flash column chromatography (silica; EtOAc-cyclohexane from 0/100 to 50/50). The desired fractions were collected and concentrated in vacuo to obtain the product as a racemic mixture N-(2- hydroxyethyl)-4-(2-((tetrahydro-2H-pyran-2-yl)methyl)-2H-tetrazol-5-yl)benzenesulfonamide (49 mg, 0.133 mmol, 28%). NMR (400 MHz, Acetone-d6) delta 7.84-7.78 (m, 2H), 7.56-7.50 (m, 2H), 7.33 (t, J = 5.9 Hz, 1 H), 4.37-4.32 (m, 2H), 4.25 (t, J = 5.6 Hz, 1 H), 3.50-3.44 (m, 1 H), 3.38-3.32 (m, 1 H), 2.94-2.90 (m, 2H), 2.86-2.80 (m, 1 H), 2.41-2.37 (m, 2H), 1.40-1.25 (m, 2H), 1.12-0.85 (m, 4H). MS m/z [M-H]"= 366.2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20 - 50℃;Inert atmosphere; | N-ethyl-N-isopropylpropan-2-amine (349 muIota_, 1.998 mmol) was added to a stirred solution of 2-methoxy-4-(2H-tetrazol-5-yl)benzenesulfonamide (170mg, 0.666 mmol, Intermediate 51 ) and <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (202 mg, 0.799 mmol, commercial source: Aldrich) in Lambda/,/V-Dimethylformamide (DMF) (2220 muIota_) under nitrogen atmosphere. After 10 minutes the mixture turned black. The solution was stirred at rt for 3h. The mixture was stirred at rt over the weekend. <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> (238 mg, 0.940 mmol, commercial source: Aldrich) and N-ethyl-N-isopropylpropan-2-amine (41 1 muIota_, 2.351 mmol) were added and the mixture was stirred at rt for 2 hours. There was some starting material, so the mixture was heated at 50C for 2 hours. The reaction mixture was diluted with water and extracted with DCM twice. The crude compound was purified by flash column chromatography (silica; EtOAc-cyclohexane from 0/100 to 100/0) for 25 min. The fractions were collected and concentrated in vacuo to obtain 2-methoxy-4-(2-(pyridin-4-ylmethyl)-2H- tetrazol-5-yl)benzenesulfonamide (150mg, 0.433 mmol, 65%) as a white solid.1H NMR (DMSO-de) delta 8.65-8.56 (m, 1 H), 7.91 (d, J = 8.6 Hz, 1 H), 7.80-7.71 (m, 2H), 7.38-7.30 (m, 2H), 7.25 (s, 2H), 6.15 (s, 2H), 4.01 (s, 3H). MS m/z [M+H]+= 347.10 . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57.7% | With caesium carbonate; In N,N-dimethyl-formamide; at 20 - 50℃; for 16h; | To a stirred solution of 6-bromo-1 H-pyrrolo[3,2-c]pyridine (1 g, 5.07 mmol) in DMF (25 mL), CS2CO3 (4.95 g, 15.21 mmol) and 4-(bromomethyl)pyridine hydrobromide (1 .92 g, 7.60 mmol) were added. The resulting suspension was allowed to stir at rt, and then heated to 50C for 16 h. The reaction mixture was poured into ice water and extracted with EtOAc (2 x 120 mL). The organic layer was washed with water and brine solution, dried over anhydrous Na2S04, and filtered. The resulting solution was concentrated under reduced pressure to get a crude residue that was purified by flash column chromatography in 230-400 silica gel 70 % EtOAc/ pet ether as an eluent to afford the title compound (800 mg, 57.7 %) of the title compound as a light brown solid. LC-MS (method 15): Rt = 2.33 min; m/z = 288.27 (M+H*). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77.8% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; | Will contain compound 16 (150 mg, 0.386 mmol), Potassium carbonate (138 mg, 1.0 mmol), 4-bromomethylpyridine hydrobromide (102 mg, 0.403 mmol) the mixture with DMF (5 mL) was stirred at room temperature overnight.Water (20 mL) was added and extracted with ethyl acetate (20 mL×3).The combined organic phases were washed sequentially with water (15 mL) and brine (15 mL). Dry over anhydrous sodium sulfate. Evaporate the solvent under reduced pressure.The product is purified by column chromatography (200-300 mesh silica gel,Ethyl acetate: dichloromethane = 1:1 to 10:1 elution),2-[4-Methoxy-3-(pyridin-4-ylmethoxy)-phenyl]-5,7-bis(methoxymethoxy)-4H-benzopyran-4-one (17) (144 mg).The yield was 77.8%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With 18-crown-6 ether; potassium carbonate; In acetone; at 55℃; | General procedure: To a stirred solution of the phenol derivative (1 mmol) in acetone(2 mL) the appropriate bromide (1.1 eq, 1.1 mmol), K2CO3 (6.6 eq,456 mg, 3.3 mmol) and a catalytic amount of 18 crown-6-ether (20 mg,8%) were added consecutively. The reaction mixture was refluxedovernight at 55 C and the solvent was evaporated under reducedpressure. The residue was dissolved in AcOEt and washed with brineand H2O to neutral pH. The organic layer was dried over Na2SO4, filteredand evaporated under reduced pressure. Purification was achieved by column chromatography, eluting with the appropriatesolvents as defined for each case below. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | With caesium carbonate; In acetone; at 20℃; for 4h; | A mixture of tert- butyl 4-hydroxyphenethylcarbamate (516 mg, 2.17 mol), cesium carbonate (1.94 g, 5.94 mmol) and 4-(bromomethyl)pyridine hydrobromide (0.5 g, 1.98 mmol) in acetone (10 mL) was stirred at room temperature for 4 h. The reaction mixture was filtrated. The filtrate was concentrated and purified by column chromatography (hexane:EtOAc = 2: 1) to afford the title compound as white solid (0.63 g, 66% yield). NMR (500 MHz, DMSO-r/6) S: 8.58 (dd, 1H), 7.42 (d, 2H), 7.10 (d, 2H), 6.94 (d, 2H), 6.84 (t, 1H), 5.15 (s, 2H), 3.10 (q, 2H), 2.62 (t, 2H), 1.18 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With potassium carbonate; potassium iodide; In N,N-dimethyl-formamide; at 40℃;Inert atmosphere; | General procedure: The nucleobase, K2CO3 and catalytic amounts of KI were mixedin dry DMF. The suspension was degassed with argon for 15 min. Asolution of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong> in dry DMFwas added slowly to the suspension. The mixture was stirred underargon at 40C overnight and the reaction progress was followed byTLC. The crude was dried under vacuum and puried by columnchromatography (silica gel, MeOH: Et3N: DCM 1:0.2:20). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | Cytosine-pyridine (2) was obtained by mixing cytosine (0.65 g,5.93 mmol, 3 eq) and KI (10 mg, catalytic amount) in 10 mL of dry DMF. After degassing the suspension with argon for 15 min, NaH(0.118 g, 4.9 mmol, 2.5 eq) was added and the mixture was stirredfor 30 min. A solution of <strong>[73870-24-3]4-(bromomethyl)pyridine hydrobromide</strong>(0.5 g, 1.97 mmol, 1 eq) in 4 mL of dry DMF was slowly added to themixture. The mixture was stirred at 40C overnight and the reac-tion progress was followed by TLC. The crude was dried undervacuum and then washed with a minimum amount of water. Theproduct was puried by column chromatography (silica gel, MeOH:Et3N: DCM 1:0.2:20) affording compound 2 (120 mg, 30%) as awhite powder; dH (500 MHz, DMSO-d6) 4.87 (2H, s, Ha), 5.73 (1H, d,3J 7.2 Hz, Hb), 7.08 (1H, s, brd, NH), 7.17 (2H, d,3J 6.0 Hz, Hm),7.21 (1H, s, brd, NH), 7.69 (1H, d,3J 7.2 Hz, Hc), 8.50 (2H, d,3J 6.0 Hz, Ho); dC (126 MHz, DMSO-d6) 50.6 (Ca), 93.9 (Cb), 122.0(Cm), 146.1 (Cc), 147.0 (Cp), 149.7 (Co), 155.7 (Cd), 166.1 (Ce); HRMS(ESI): MH, found 203.0934. C10H10N4O requires 203.0927; IR(cm1): 3337.24, 3115.39, 1652.03, 1597.71, 1486.09, 1423.17,1384.39, 1369.72, 1278.91, 1208.06, 1130.29, 965.29, 815.97, 781.56,704.43, 682.80, 567.57, 521.43, 474.65, 405.44. |
Tags: 73870-24-3 synthesis path| 73870-24-3 SDS| 73870-24-3 COA| 73870-24-3 purity| 73870-24-3 application| 73870-24-3 NMR| 73870-24-3 COA| 73870-24-3 structure
[ 83004-14-2 ]
2-Bromo-4-(bromomethyl)pyridine
Similarity: 0.90
[ 32938-44-6 ]
2-Bromo-4-(bromomethyl)pyridine hydrobromide
Similarity: 0.90
[ 1384972-83-1 ]
3-(Bromomethyl)-4-methylpyridine hydrobromide
Similarity: 0.89
[ 120277-01-2 ]
4-(2-Bromoethyl)pyridine hydrobromide
Similarity: 0.85
[ 83004-14-2 ]
2-Bromo-4-(bromomethyl)pyridine
Similarity: 0.90
[ 32938-44-6 ]
2-Bromo-4-(bromomethyl)pyridine hydrobromide
Similarity: 0.90
[ 1384972-83-1 ]
3-(Bromomethyl)-4-methylpyridine hydrobromide
Similarity: 0.89
[ 120277-01-2 ]
4-(2-Bromoethyl)pyridine hydrobromide
Similarity: 0.85
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :